[10-Q] Addus HomeCare Corp. Quarterly Earnings Report
Form 144 filed for Arteris, Inc. (AIP) discloses that insider Nicholas Hawkins plans to sell 11,276 common shares on 5 Aug 2025 through Morgan Stanley Smith Barney. The shares are valued at $106,558, implying an estimated price of roughly $9.46 each. Arteris has 41.98 million shares outstanding, so the proposed sale equals ~0.03 % of the float.
The filing also details the insider’s trading activity over the prior three months: 60,324 shares have already been sold under a Rule 10b5-1 plan, generating about $488 k in gross proceeds. These prior disposals occurred on 13 separate dates between 8 May 2025 and 1 Aug 2025, with individual block sizes ranging from 438 to 11,000 shares.
All shares being sold were acquired via stock-option exercises on 18 Oct 2021 and paid for in cash. The signer certifies no undisclosed material adverse information. While the absolute number of shares is small relative to Arteris’s capitalization, the steady cadence of insider selling may draw investor attention to management’s sentiment and share-based compensation practices.
Il modulo 144 presentato per Arteris, Inc. (AIP) rivela che l'insider Nicholas Hawkins intende vendere 11.276 azioni ordinarie il 5 agosto 2025 tramite Morgan Stanley Smith Barney. Le azioni sono valutate 106.558 $, con un prezzo stimato di circa 9,46 $ ciascuna. Arteris ha 41,98 milioni di azioni in circolazione, quindi la vendita proposta rappresenta circa il 0,03% del flottante.
La comunicazione dettaglia anche l'attività di trading dell'insider negli ultimi tre mesi: sono già state vendute 60.324 azioni nell'ambito di un piano Rule 10b5-1, generando circa 488 mila $ di proventi lordi. Queste vendite precedenti sono avvenute in 13 date diverse tra l'8 maggio 2025 e il 1° agosto 2025, con blocchi singoli che variano da 438 a 11.000 azioni.
Tutte le azioni vendute sono state acquisite tramite esercizio di stock option il 18 ottobre 2021 e pagate in contanti. Il firmatario certifica l'assenza di informazioni materiali sfavorevoli non divulgate. Sebbene il numero assoluto di azioni sia piccolo rispetto alla capitalizzazione di Arteris, la costante frequenza di vendite da parte degli insider potrebbe attirare l'attenzione degli investitori sul sentiment del management e sulle pratiche di compensazione basate sulle azioni.
El formulario 144 presentado para Arteris, Inc. (AIP) revela que el insider Nicholas Hawkins planea vender 11,276 acciones ordinarias el 5 de agosto de 2025 a través de Morgan Stanley Smith Barney. Las acciones están valoradas en 106,558 $, lo que implica un precio estimado de aproximadamente 9.46 $ cada una. Arteris tiene 41.98 millones de acciones en circulación, por lo que la venta propuesta equivale a aproximadamente el 0.03% del flotante.
La presentación también detalla la actividad comercial del insider durante los últimos tres meses: ya se han vendido 60,324 acciones bajo un plan Rule 10b5-1, generando alrededor de 488 mil $ en ingresos brutos. Estas ventas previas ocurrieron en 13 fechas diferentes entre el 8 de mayo de 2025 y el 1 de agosto de 2025, con bloques individuales que van de 438 a 11,000 acciones.
Todas las acciones vendidas fueron adquiridas mediante ejercicios de opciones sobre acciones el 18 de octubre de 2021 y pagadas en efectivo. El firmante certifica que no hay información material adversa no divulgada. Aunque el número absoluto de acciones es pequeño en relación con la capitalización de Arteris, la constante frecuencia de ventas de insiders podría llamar la atención de los inversores sobre el sentimiento de la dirección y las prácticas de compensación basadas en acciones.
Arteris, Inc. (AIP)에 대해 제출된 144 양식에 따르면 내부자 Nicholas Hawkins가 2025년 8월 5일에 Morgan Stanley Smith Barney를 통해 11,276주의 보통주를 매도할 계획임을 공개했습니다. 해당 주식의 가치는 106,558달러로, 주당 약 9.46달러로 추정됩니다. Arteris의 발행 주식 수는 4,198만 주로, 이번 매도는 유통 주식의 약 0.03%에 해당합니다.
또한 제출서류는 내부자의 지난 3개월간 거래 내역을 상세히 밝히고 있습니다: Rule 10b5-1 계획에 따라 이미 60,324주가 매도되어 약 48만 8천 달러의 총 수익을 창출했습니다. 이 이전 매도는 2025년 5월 8일부터 8월 1일까지 13회에 걸쳐 이루어졌으며, 개별 거래 규모는 438주에서 11,000주 사이였습니다.
매도되는 모든 주식은 2021년 10월 18일 주식 옵션 행사를 통해 취득하였으며 현금으로 결제되었습니다. 서명자는 공개되지 않은 중대한 불리한 정보가 없음을 인증합니다. Arteris의 시가총액에 비해 주식 수는 적지만, 내부자의 꾸준한 매도 행보는 경영진의 심리와 주식 기반 보상 관행에 투자자들의 관심을 끌 수 있습니다.
Le formulaire 144 déposé pour Arteris, Inc. (AIP) révèle que l’initié Nicholas Hawkins prévoit de vendre 11 276 actions ordinaires le 5 août 2025 via Morgan Stanley Smith Barney. Les actions sont valorisées à 106 558 $, ce qui implique un prix estimé d’environ 9,46 $ chacune. Arteris compte 41,98 millions d’actions en circulation, donc la vente proposée représente environ 0,03 % du flottant.
Le dépôt détaille également l’activité de trading de l’initié au cours des trois derniers mois : 60 324 actions ont déjà été vendues dans le cadre d’un plan Rule 10b5-1, générant environ 488 000 $ de recettes brutes. Ces ventes antérieures ont eu lieu à 13 dates différentes entre le 8 mai 2025 et le 1er août 2025, avec des blocs individuels allant de 438 à 11 000 actions.
Toutes les actions vendues ont été acquises via l’exercice d’options d’achat d’actions le 18 octobre 2021 et réglées en espèces. Le signataire certifie qu’aucune information défavorable importante non divulguée n’existe. Bien que le nombre absolu d’actions soit faible par rapport à la capitalisation d’Arteris, la fréquence régulière des ventes par les initiés pourrait attirer l’attention des investisseurs sur le sentiment de la direction et les pratiques de rémunération basées sur les actions.
Das eingereichte Formular 144 für Arteris, Inc. (AIP) zeigt, dass Insider Nicholas Hawkins plant, am 5. August 2025 11.276 Stammaktien über Morgan Stanley Smith Barney zu verkaufen. Die Aktien haben einen Wert von 106.558 $, was auf einen geschätzten Preis von etwa 9,46 $ pro Aktie hindeutet. Arteris hat 41,98 Millionen ausstehende Aktien, somit entspricht der geplante Verkauf etwa 0,03 % des Streubesitzes.
Die Einreichung enthält auch Details zu den Handelsaktivitäten des Insiders in den letzten drei Monaten: Bereits 60.324 Aktien wurden im Rahmen eines Rule 10b5-1-Plans verkauft, was Bruttoerlöse von etwa 488.000 $ generierte. Diese Verkäufe erfolgten an 13 verschiedenen Terminen zwischen dem 8. Mai 2025 und dem 1. August 2025, mit einzelnen Blockgrößen von 438 bis 11.000 Aktien.
Alle verkauften Aktien wurden durch Ausübung von Aktienoptionen am 18. Oktober 2021 erworben und bar bezahlt. Der Unterzeichner bestätigt, dass keine nicht offengelegten wesentlichen nachteiligen Informationen vorliegen. Obwohl die absolute Anzahl der Aktien im Verhältnis zur Marktkapitalisierung von Arteris gering ist, könnte die stetige Verkaufsaktivität der Insider die Aufmerksamkeit der Investoren auf die Stimmung des Managements und die aktienbasierten Vergütungspraktiken lenken.
- Rule 10b5-1 plan mitigates concerns about trading on non-public information
- Sale size is only ~0.03 % of shares outstanding, posing negligible dilution or market impact
- Continued insider selling (>60 k shares in past 3 months plus new 11 k notice) may signal limited insider confidence
- Aggregate proceeds ~$0.6 M in a short window could pressure sentiment in the absence of offsetting insider buys
Insights
TL;DR: Multiple 10b5-1 sales and new Form 144 indicate ongoing insider monetization, mildly negative for sentiment.
The filing signals continued disposal of shares by Nicholas Hawkins. Although Rule 10b5-1 plans reduce the risk of information asymmetry, the cumulative sale of >60 k shares in three months plus a fresh 11 k-share notice may be interpreted as waning insider confidence or simple diversification. The amount is immaterial to the float, but frequent filings keep insider-selling headlines alive, which can pressure the stock in low-liquidity periods. No red flags regarding undisclosed adverse information are claimed.
TL;DR: Transaction is immaterial to fundamentals; treat as neutral unless insider selling trend accelerates.
At 0.03 % of outstanding shares and ~$0.1 M value, this planned sale will not affect supply-demand dynamics. Arteris trades millions of dollars daily, so execution risk is minimal. Investors should monitor if other executives follow suit or if Hawkins’s remaining holdings shrink materially. Absent macro context or earnings data, the event is not impactful to valuation models but could weigh on short-term sentiment.
Il modulo 144 presentato per Arteris, Inc. (AIP) rivela che l'insider Nicholas Hawkins intende vendere 11.276 azioni ordinarie il 5 agosto 2025 tramite Morgan Stanley Smith Barney. Le azioni sono valutate 106.558 $, con un prezzo stimato di circa 9,46 $ ciascuna. Arteris ha 41,98 milioni di azioni in circolazione, quindi la vendita proposta rappresenta circa il 0,03% del flottante.
La comunicazione dettaglia anche l'attività di trading dell'insider negli ultimi tre mesi: sono già state vendute 60.324 azioni nell'ambito di un piano Rule 10b5-1, generando circa 488 mila $ di proventi lordi. Queste vendite precedenti sono avvenute in 13 date diverse tra l'8 maggio 2025 e il 1° agosto 2025, con blocchi singoli che variano da 438 a 11.000 azioni.
Tutte le azioni vendute sono state acquisite tramite esercizio di stock option il 18 ottobre 2021 e pagate in contanti. Il firmatario certifica l'assenza di informazioni materiali sfavorevoli non divulgate. Sebbene il numero assoluto di azioni sia piccolo rispetto alla capitalizzazione di Arteris, la costante frequenza di vendite da parte degli insider potrebbe attirare l'attenzione degli investitori sul sentiment del management e sulle pratiche di compensazione basate sulle azioni.
El formulario 144 presentado para Arteris, Inc. (AIP) revela que el insider Nicholas Hawkins planea vender 11,276 acciones ordinarias el 5 de agosto de 2025 a través de Morgan Stanley Smith Barney. Las acciones están valoradas en 106,558 $, lo que implica un precio estimado de aproximadamente 9.46 $ cada una. Arteris tiene 41.98 millones de acciones en circulación, por lo que la venta propuesta equivale a aproximadamente el 0.03% del flotante.
La presentación también detalla la actividad comercial del insider durante los últimos tres meses: ya se han vendido 60,324 acciones bajo un plan Rule 10b5-1, generando alrededor de 488 mil $ en ingresos brutos. Estas ventas previas ocurrieron en 13 fechas diferentes entre el 8 de mayo de 2025 y el 1 de agosto de 2025, con bloques individuales que van de 438 a 11,000 acciones.
Todas las acciones vendidas fueron adquiridas mediante ejercicios de opciones sobre acciones el 18 de octubre de 2021 y pagadas en efectivo. El firmante certifica que no hay información material adversa no divulgada. Aunque el número absoluto de acciones es pequeño en relación con la capitalización de Arteris, la constante frecuencia de ventas de insiders podría llamar la atención de los inversores sobre el sentimiento de la dirección y las prácticas de compensación basadas en acciones.
Arteris, Inc. (AIP)에 대해 제출된 144 양식에 따르면 내부자 Nicholas Hawkins가 2025년 8월 5일에 Morgan Stanley Smith Barney를 통해 11,276주의 보통주를 매도할 계획임을 공개했습니다. 해당 주식의 가치는 106,558달러로, 주당 약 9.46달러로 추정됩니다. Arteris의 발행 주식 수는 4,198만 주로, 이번 매도는 유통 주식의 약 0.03%에 해당합니다.
또한 제출서류는 내부자의 지난 3개월간 거래 내역을 상세히 밝히고 있습니다: Rule 10b5-1 계획에 따라 이미 60,324주가 매도되어 약 48만 8천 달러의 총 수익을 창출했습니다. 이 이전 매도는 2025년 5월 8일부터 8월 1일까지 13회에 걸쳐 이루어졌으며, 개별 거래 규모는 438주에서 11,000주 사이였습니다.
매도되는 모든 주식은 2021년 10월 18일 주식 옵션 행사를 통해 취득하였으며 현금으로 결제되었습니다. 서명자는 공개되지 않은 중대한 불리한 정보가 없음을 인증합니다. Arteris의 시가총액에 비해 주식 수는 적지만, 내부자의 꾸준한 매도 행보는 경영진의 심리와 주식 기반 보상 관행에 투자자들의 관심을 끌 수 있습니다.
Le formulaire 144 déposé pour Arteris, Inc. (AIP) révèle que l’initié Nicholas Hawkins prévoit de vendre 11 276 actions ordinaires le 5 août 2025 via Morgan Stanley Smith Barney. Les actions sont valorisées à 106 558 $, ce qui implique un prix estimé d’environ 9,46 $ chacune. Arteris compte 41,98 millions d’actions en circulation, donc la vente proposée représente environ 0,03 % du flottant.
Le dépôt détaille également l’activité de trading de l’initié au cours des trois derniers mois : 60 324 actions ont déjà été vendues dans le cadre d’un plan Rule 10b5-1, générant environ 488 000 $ de recettes brutes. Ces ventes antérieures ont eu lieu à 13 dates différentes entre le 8 mai 2025 et le 1er août 2025, avec des blocs individuels allant de 438 à 11 000 actions.
Toutes les actions vendues ont été acquises via l’exercice d’options d’achat d’actions le 18 octobre 2021 et réglées en espèces. Le signataire certifie qu’aucune information défavorable importante non divulguée n’existe. Bien que le nombre absolu d’actions soit faible par rapport à la capitalisation d’Arteris, la fréquence régulière des ventes par les initiés pourrait attirer l’attention des investisseurs sur le sentiment de la direction et les pratiques de rémunération basées sur les actions.
Das eingereichte Formular 144 für Arteris, Inc. (AIP) zeigt, dass Insider Nicholas Hawkins plant, am 5. August 2025 11.276 Stammaktien über Morgan Stanley Smith Barney zu verkaufen. Die Aktien haben einen Wert von 106.558 $, was auf einen geschätzten Preis von etwa 9,46 $ pro Aktie hindeutet. Arteris hat 41,98 Millionen ausstehende Aktien, somit entspricht der geplante Verkauf etwa 0,03 % des Streubesitzes.
Die Einreichung enthält auch Details zu den Handelsaktivitäten des Insiders in den letzten drei Monaten: Bereits 60.324 Aktien wurden im Rahmen eines Rule 10b5-1-Plans verkauft, was Bruttoerlöse von etwa 488.000 $ generierte. Diese Verkäufe erfolgten an 13 verschiedenen Terminen zwischen dem 8. Mai 2025 und dem 1. August 2025, mit einzelnen Blockgrößen von 438 bis 11.000 Aktien.
Alle verkauften Aktien wurden durch Ausübung von Aktienoptionen am 18. Oktober 2021 erworben und bar bezahlt. Der Unterzeichner bestätigt, dass keine nicht offengelegten wesentlichen nachteiligen Informationen vorliegen. Obwohl die absolute Anzahl der Aktien im Verhältnis zur Marktkapitalisierung von Arteris gering ist, könnte die stetige Verkaufsaktivität der Insider die Aufmerksamkeit der Investoren auf die Stimmung des Managements und die aktienbasierten Vergütungspraktiken lenken.
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
| | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended
OR
| | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number
ADDUS HOMECARE CORPORATION
(Exact name of registrant as specified in its charter)
|
| |
| | |
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
| | |
| (Address of principal executive offices) | (Zip Code) |
(
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| | | The |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| | ☒ | Accelerated Filer | ☐ |
| Non-Accelerated Filer | ☐ | Smaller Reporting Company | |
| Emerging Growth Company | |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
As of July 29, 2025, Addus HomeCare Corporation had
ADDUS HOMECARE CORPORATION
FORM 10-Q
INDEX
| PART I. FINANCIAL INFORMATION |
4 |
| Item 1. Financial Statements (Unaudited) |
4 |
| Condensed Consolidated Balance Sheets as of June 30, 2025 and December 31, 2024 |
4 |
| Condensed Consolidated Statements of Income For the Three and Six Months Ended June 30, 2025 and 2024 |
5 |
| Condensed Consolidated Statement of Stockholders’ Equity For the Three and Six Months Ended June 30, 2025 and 2024 |
6 |
| Condensed Consolidated Statements of Cash Flows For the Six Months Ended June 30, 2025 and 2024 |
8 |
| Notes to Condensed Consolidated Financial Statements |
9 |
| Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations |
23 |
| Item 3. Quantitative and Qualitative Disclosures About Market Risk |
40 |
| Item 4. Controls and Procedures |
40 |
| PART II. OTHER INFORMATION |
41 |
| Item 1. Legal Proceedings |
41 |
| Item 1A. Risk Factors |
41 |
| Item 2. Unregistered Sales of Equity Securities and Use of Proceeds |
41 |
| Item 3. Defaults Upon Senior Securities |
41 |
| Item 4. Mine Safety Disclosures |
41 |
| Item 5. Other Information |
41 |
| Item 6. Exhibits |
42 |
PART I – FINANCIAL INFORMATION
Item 1. Financial Statements
ADDUS HOMECARE CORPORATION
AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
As of June 30, 2025 and December 31, 2024
(Amounts and Shares in Thousands, Except Per Share Data)
(Unaudited)
| June 30, 2025 | December 31, 2024 | |||||||
| Assets | ||||||||
| Current assets | ||||||||
| Cash | $ | $ | ||||||
| Accounts receivable, net of allowances | ||||||||
| Prepaid expenses and other current assets | ||||||||
| Total current assets | ||||||||
| Property and equipment, net of accumulated depreciation and amortization | ||||||||
| Other assets | ||||||||
| Goodwill | ||||||||
| Intangibles, net of accumulated amortization | ||||||||
| Operating lease assets, net | ||||||||
| Total other assets | ||||||||
| Total assets | $ | $ | ||||||
| Liabilities and stockholders' equity | ||||||||
| Current liabilities | ||||||||
| Accounts payable | $ | $ | ||||||
| Accrued payroll | ||||||||
| Accrued expenses | ||||||||
| Operating lease liabilities, current portion | ||||||||
| Government stimulus advances | ||||||||
| Accrued workers' compensation insurance | ||||||||
| Total current liabilities | ||||||||
| Long-term liabilities | ||||||||
| Long-term debt, less current portion, net of debt issuance costs | ||||||||
| Long-term operating lease liabilities | ||||||||
| Deferred income tax | ||||||||
| Other long-term liabilities | ||||||||
| Total long-term liabilities | ||||||||
| Total liabilities | $ | $ | ||||||
| Stockholders' equity | ||||||||
| Common stock—$.001 par value; 40,000 authorized and 18,407 and 18,148 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively | $ | $ | ||||||
| Additional paid-in capital | ||||||||
| Retained earnings | ||||||||
| Total stockholders' equity | ||||||||
| Total liabilities and stockholders' equity | $ | $ | ||||||
See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)
ADDUS HOMECARE CORPORATION
AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
For the Three and Six Months Ended June 30, 2025 and 2024
(Amounts and Shares in Thousands, Except Per Share Data)
(Unaudited)
| For the Three Months Ended |
For the Six Months Ended |
|||||||||||||||
| June 30, |
June 30, |
|||||||||||||||
| 2025 |
2024 |
2025 |
2024 |
|||||||||||||
| Net service revenues |
$ | $ | $ | $ | ||||||||||||
| Cost of service revenues |
||||||||||||||||
| Gross profit |
||||||||||||||||
| General and administrative expenses |
||||||||||||||||
| Depreciation and amortization |
||||||||||||||||
| Total operating expenses |
||||||||||||||||
| Operating income |
||||||||||||||||
| Interest income |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
| Interest expense |
||||||||||||||||
| Total interest expense, net |
||||||||||||||||
| Income before income taxes |
||||||||||||||||
| Income tax expense |
||||||||||||||||
| Net income |
$ | $ | $ | $ | ||||||||||||
| Net income per common share |
||||||||||||||||
| Basic income per share |
$ | $ | $ | $ | ||||||||||||
| Diluted income per share |
$ | $ | $ | $ | ||||||||||||
| Weighted average number of common shares and potential common shares outstanding: |
||||||||||||||||
| Basic |
||||||||||||||||
| Diluted |
||||||||||||||||
See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)
ADDUS HOMECARE CORPORATION
AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
For the Three and Six Months Ended June 30, 2025
(Amounts and Shares in Thousands)
(Unaudited)
| For the Three Months Ended June 30, 2025 |
||||||||||||||||||||
| Additional |
Total |
|||||||||||||||||||
| Common Stock |
Paid-in |
Retained |
Stockholders' |
|||||||||||||||||
| Shares |
Amount |
Capital |
Earnings |
Equity |
||||||||||||||||
| Balance at April 1, 2025 |
$ | $ | $ | $ | ||||||||||||||||
| Issuance of shares of common stock under restricted stock award agreements |
||||||||||||||||||||
| Forfeiture of shares of common stock under restricted stock award agreements |
( |
) | ||||||||||||||||||
| Stock-based compensation |
— | |||||||||||||||||||
| Shares issued for exercise of stock options |
||||||||||||||||||||
| Net income |
— | |||||||||||||||||||
| Balance at June 30, 2025 |
$ | $ | $ | $ | ||||||||||||||||
| For the Six Months Ended June 30, 2025 |
||||||||||||||||||||
| Additional |
Total |
|||||||||||||||||||
| Common Stock |
Paid-in |
Retained |
Stockholders' |
|||||||||||||||||
| Shares |
Amount |
Capital |
Earnings |
Equity |
||||||||||||||||
| Balance at January 1, 2025 |
$ | $ | $ | $ | ||||||||||||||||
| Issuance of shares of common stock under restricted stock award agreements |
||||||||||||||||||||
| Forfeiture of shares of common stock under restricted stock award agreements |
( |
) | ||||||||||||||||||
| Stock-based compensation |
— | |||||||||||||||||||
| Shares issued for exercise of stock options |
||||||||||||||||||||
| Net income |
— | |||||||||||||||||||
| Balance at June 30, 2025 |
$ | $ | $ | $ | ||||||||||||||||
ADDUS HOMECARE CORPORATION
AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
For the Three and Six Months Ended June 30, 2024
(Amounts and Shares in Thousands)
(Unaudited)
| For the Three Months Ended June 30, 2024 |
||||||||||||||||||||
| Additional |
Total |
|||||||||||||||||||
| Common Stock |
Paid-in |
Retained |
Stockholders' |
|||||||||||||||||
| Shares |
Amount |
Capital |
Earnings |
Equity |
||||||||||||||||
| Balance at April 1, 2024 |
$ | $ | $ | $ | ||||||||||||||||
| Issuance of shares of common stock under restricted stock award agreements |
||||||||||||||||||||
| Forfeiture of shares of common stock under restricted stock award agreements |
( |
) | ||||||||||||||||||
| Stock-based compensation |
— | |||||||||||||||||||
| Shares issued for exercise of stock options |
||||||||||||||||||||
| Shares issued in Public offering, net of offering costs |
||||||||||||||||||||
| Net income |
— | |||||||||||||||||||
| Balance at June 30, 2024 |
$ | $ | $ | $ | ||||||||||||||||
| For the Six Months Ended June 30, 2024 |
||||||||||||||||||||
| Additional |
Total |
|||||||||||||||||||
| Common Stock |
Paid-in |
Retained |
Stockholders' |
|||||||||||||||||
| Shares |
Amount |
Capital |
Earnings |
Equity |
||||||||||||||||
| Balance at January 1, 2024 |
$ | $ | $ | $ | ||||||||||||||||
| Issuance of shares of common stock under restricted stock award agreements |
||||||||||||||||||||
| Forfeiture of shares of common stock under restricted stock award agreements |
( |
) | ||||||||||||||||||
| Stock-based compensation |
— | |||||||||||||||||||
| Shares issued for exercise of stock options |
||||||||||||||||||||
| Shares issued in Public offering, net of offering costs |
||||||||||||||||||||
| Net income |
— | |||||||||||||||||||
| Balance at June 30, 2024 |
$ | $ | $ | $ | ||||||||||||||||
See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)
ADDUS HOMECARE CORPORATION
AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Six Months Ended June 30, 2025 and 2024
(Amounts in Thousands)
(Unaudited)
| For the Six Months Ended |
||||||||
| June 30, |
||||||||
| 2025 |
2024 |
|||||||
| Cash flows from operating activities: |
||||||||
| Net income |
$ | $ | ||||||
| Adjustments to reconcile net income to net cash provided by (used in) operating activities, net of acquisitions: |
||||||||
| Depreciation and amortization |
||||||||
| Deferred income taxes |
||||||||
| Stock-based compensation |
||||||||
| Amortization of debt issuance costs under the credit facility |
||||||||
| Provision for credit losses |
||||||||
| Gain on disposal of assets |
( |
) | ( |
) | ||||
| Loss on termination of operating leases |
||||||||
| Changes in operating assets and liabilities, net of acquisitions: |
||||||||
| Accounts receivable |
( |
) | ||||||
| Prepaid expenses and other current assets |
||||||||
| Government stimulus advances |
( |
) | ||||||
| Accounts payable |
( |
) | ( |
) | ||||
| Accrued payroll |
( |
) | ||||||
| Accrued expenses and other long-term liabilities |
( |
) | ||||||
| Net cash provided by operating activities |
||||||||
| Cash flows from investing activities: |
||||||||
| Acquisitions of businesses, net of cash acquired |
( |
) | ( |
) | ||||
| Purchases of property and equipment |
( |
) | ( |
) | ||||
| Proceeds received from disposal of assets |
||||||||
| Proceeds received from previous acquisition |
||||||||
| Proceeds received from divestiture of business |
||||||||
| Net cash used in investing activities |
||||||||
| Cash flows from financing activities: |
||||||||
| Payments on revolver — credit facility |
( |
) | ( |
) | ||||
| Payments for debt issuance costs under the credit facility |
( |
) | ||||||
| Proceeds from Public offering |
||||||||
| Cash received from exercise of stock options |
||||||||
| Net cash (used in) provided by financing activities |
( |
) | ||||||
| Net change in cash |
( |
) | ||||||
| Cash, at beginning of period |
||||||||
| Cash, at end of period |
$ | $ | ||||||
| Supplemental disclosures of cash flow information: |
||||||||
| Cash paid for interest |
$ | $ | ||||||
| Cash paid for income taxes |
||||||||
See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)
ADDUS HOMECARE CORPORATION
AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(Unaudited)
1. Nature of Operations, Consolidation, and Presentation of Financial Statements
Addus HomeCare Corporation (“Holdings”) and its subsidiaries (together with Holdings, the “Company”, “we”, “us”, or “our”) operate as a multi-state provider of three distinct but related business segments providing in-home services. In its personal care segment, the Company provides non-medical assistance with activities of daily living, primarily to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill, or disabled. In its hospice segment, the Company provides physical, emotional, and spiritual care for people who are terminally ill as well as related services for their families. In its home health segment, the Company provides services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational, and speech therapy. The Company’s payors include federal, state, and local governmental agencies, managed care organizations, commercial insurers, and private individuals.
Basis of Presentation
The accompanying Unaudited Condensed Consolidated Financial Statements and related notes have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for Quarterly Reports on Form 10-Q. The accompanying balance sheet as of December 31, 2024 has been derived from the Company’s audited financial statements for the year ended December 31, 2024 previously filed with the SEC. Accordingly, these financial statements do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America (“GAAP”) for annual financial statements and should be read in conjunction with our consolidated financial statements and notes thereto for the year ended December 31, 2024 included in our Annual Report on Form 10-K, which includes information and disclosures not included herein.
In the opinion of management, these financial statements reflect all adjustments of a normal, recurring nature necessary for the fair statement of our financial position, results of operations, and cash flows for the interim periods presented in conformity with GAAP. Our results for any interim period are not necessarily indicative of results for a full year or any other interim period.
Principles of Consolidation
These Unaudited Condensed Consolidated Financial Statements include the accounts of Addus HomeCare Corporation and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
2. Summary of Significant Accounting Policies
Estimates
The financial statements are prepared by management in conformity with GAAP and include estimated amounts and certain disclosures based on assumptions about future events. The Company’s critical accounting estimates include the following areas: revenue recognition, goodwill and intangibles and business combinations, and when required, the quantitative assessment of goodwill. Actual results could differ from those estimates.
Computation of Weighted Average Shares
The following table sets forth the computation of basic and diluted common shares:
| For the Three Months Ended June 30, | For the Six Months Ended June 30, | |||||||||||||||
| (Amounts in thousands) | (Amounts in thousands) | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Weighted average number of shares outstanding for basic per share calculation | ||||||||||||||||
| Effect of dilutive potential shares: | ||||||||||||||||
| Stock options | ||||||||||||||||
| Restricted stock awards | ||||||||||||||||
| Adjusted weighted average shares for diluted per share calculation | ||||||||||||||||
| Anti-dilutive shares: | ||||||||||||||||
| Stock options | ||||||||||||||||
| Restricted stock awards | ||||||||||||||||
Recently Adopted Accounting Pronouncements
In November 2023, the Financial Accounting Standards Board (“FASB”) issued ASU 2023-07, Improvements to Reportable Segment Disclosures, which expands reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in the ASU require, among other things, disclosure of significant segment expenses that are regularly provided to an entity’s chief operating decision maker (“CODM”) and a description of other segment items (the difference between segment revenue less the segment expenses disclosed under the significant expense principle and each reported measure of segment profit or loss) by reportable segment, as well as disclosure of the title and position of the CODM, and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. The ASU was adopted in connection with the Company's most recent Annual Report on Form 10-K, which included significant segment expenses reviewed by the Company’s CODM, but did not have a material impact on the Company’s results of operations, financial position, or cash flows.
Recently Issued Accounting Pronouncements
In December 2023, the FASB issued ASU 2023-09, Improvement to Income Tax Disclosures, which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, may be applied on a prospective basis with the option to apply the standard retrospectively, and allows for early adoption. These requirements are not expected to have a material impact on the Company’s financial statements and will expand income tax disclosures.
In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses, which intends to provide investors more detailed disclosures around specific types of expenses. The new disclosures require certain details for expenses presented on the face of the Consolidated Statements of Operations as well as selling expenses to be presented in the notes to the financial statements. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The disclosure updates are required to be applied prospectively with the option for retrospective application. The Company is currently assessing the impact and timing of adopting the updated provisions.
3. Divestiture
Effective May 20, 2024, the Company entered into a definitive asset purchase agreement to sell all of the Company’s New York operations for a purchase price of up to $
In connection with this transaction, the Company ceased operations in New York. During the six months ended June 30, 2025, the Company recorded deferred payments of $
The New York Asset Sale did not qualify as a discontinued operation because it did not represent a strategic shift that has or will have a major effect on the Company’s operation or financial results.
Goodwill and intangible assets of $
| June 30, 2025 |
||||
| Assets |
||||
| Current assets |
||||
| Accounts receivable, net of allowances |
$ | |||
| Prepaid expenses and other current assets |
||||
| Total current assets |
||||
| Property and equipment, net of accumulated depreciation and amortization |
||||
| Other assets |
||||
| Goodwill |
||||
| Intangibles, net of accumulated amortization |
||||
| Operating lease assets, net |
||||
| Total other assets |
||||
| Total assets |
$ | |||
| Liabilities |
||||
| Current liabilities |
||||
| Accounts payable |
$ | |||
| Accrued payroll |
||||
| Accrued expenses |
||||
| Operating lease liabilities, current portion |
||||
| Total current liabilities |
||||
| Long-term liabilities |
||||
| Operating lease liabilities, long-term portion |
||||
| Total liabilities |
$ | |||
4. Leases
Amounts reported on the Company’s Unaudited Condensed Consolidated Balance Sheets for operating leases were as follows:
| June 30, 2025 |
December 31, 2024 |
|||||||
| (Amounts in Thousands) |
||||||||
| Operating lease assets, net |
$ | $ | ||||||
| Short-term operating lease liabilities |
||||||||
| Long-term operating lease liabilities |
||||||||
| Total operating lease liabilities |
$ | $ | ||||||
Lease Costs
Components of lease costs were reported in general and administrative expenses in the Company’s Unaudited Condensed Consolidated Statements of Income as follows:
| For the Three Months Ended June 30, |
For the Six Months Ended June 30, |
|||||||||||||||
| (Amounts in Thousands) |
(Amounts in Thousands) |
|||||||||||||||
| 2025 |
2024 |
2025 |
2024 |
|||||||||||||
| Operating lease costs |
$ | $ | $ | $ | ||||||||||||
| Short-term lease costs |
||||||||||||||||
| Total lease costs |
||||||||||||||||
| Less: sublease income |
( |
) | ( |
) | ( |
) | ||||||||||
| Total lease costs, net |
$ | $ | $ | $ | ||||||||||||
Lease Term and Discount Rate
Weighted average remaining lease terms and discount rates were as follows:
| June 30, 2025 |
December 31, 2024 |
|||||||
| Operating leases: |
||||||||
| Weighted average remaining lease term |
||||||||
| Weighted average discount rate |
% | % | ||||||
Maturity of Lease Liabilities
Remaining operating lease payments as of June 30, 2025 were as follows:
| Operating Leases |
||||
| (Amounts in Thousands) |
||||
| Due in the 12-month period ended June 30, |
||||
| 2026 |
$ | |||
| 2027 |
||||
| 2028 |
||||
| 2029 |
||||
| 2030 |
||||
| Thereafter |
||||
| Total future minimum rental commitments |
||||
| Less: Imputed interest |
( |
) | ||
| Total lease liabilities |
$ | |||
Supplemental Cash Flows Information
| For the Six Months Ended June 30, |
||||||||
| (Amounts in Thousands) |
||||||||
| 2025 |
2024 |
|||||||
| Cash paid for amounts included in the measurement of lease liabilities: |
||||||||
| Operating cash flows from operating leases |
$ | $ | ||||||
| Right-of-use assets obtained in exchange for lease obligations: |
||||||||
| Operating leases |
$ | $ | ||||||
5. Goodwill and Intangible Assets
A summary of the goodwill by segment and related adjustments is provided below:
| Home | ||||||||||||||||
| Hospice | Personal Care | Health | Total | |||||||||||||
| (Amounts in Thousands) | ||||||||||||||||
| Goodwill as of December 31, 2024 | $ | $ | $ | $ | ||||||||||||
| Additions for acquisitions | ||||||||||||||||
| Adjustments to previously recorded goodwill | ( | ) | ( | ) | ( | ) | ||||||||||
| Goodwill as of June 30, 2025 | $ | $ | $ | $ | ||||||||||||
On January 1, 2025, the Company completed its acquisition of its Jacksonville affiliate for approximately $
On March 1, 2025, the Company completed its acquisition of the assets of Great Lakes Home Care Unlimited, LLC for $
During the three and six months ended June 30, 2025, the Company recorded $2.5 million and $
The Company’s identifiable intangible assets consist of customer and referral relationships, trade names and trademarks, non-competition agreements, and state licenses. Amortization is computed using straight-line and accelerated methods based upon the estimated useful lives of the respective assets, which range from one to twenty years. Customer and referral relationships are amortized systematically over the periods of expected economic benefit, which range from three to fifteen years.
The carrying amount and accumulated amortization of each identifiable intangible asset category consisted of the following:
| June 30, 2025 | December 31, 2024 | ||||||||||||||||||||||||||
| (Amounts in Thousands) | (Amounts in Thousands) | ||||||||||||||||||||||||||
| Estimated Useful | Gross | Accumulated | Net | Gross | Accumulated | Net | |||||||||||||||||||||
| Life (years) | carrying value | amortization | carrying value | carrying value | amortization | carrying value | |||||||||||||||||||||
| Customer and referral relationships | $ | $ | ( | ) | $ | $ | $ | ( | ) | $ | |||||||||||||||||
| Trade names and trademarks | ( | ) | ( | ) | |||||||||||||||||||||||
| Non-competition agreement | ( | ) | ( | ) | |||||||||||||||||||||||
| State Licenses | ( | ) | ( | ) | |||||||||||||||||||||||
| State Licenses | Indefinite | — | — | ||||||||||||||||||||||||
| Total intangible assets | $ | $ | ( | ) | $ | $ | $ | ( | ) | $ | |||||||||||||||||
Amortization expense related to the intangible assets was $
6. Details of Certain Balance Sheet Accounts
Prepaid expenses and other current assets consisted of the following:
| June 30, 2025 |
December 31, 2024 |
|||||||
| (Amounts in Thousands) |
||||||||
| Income tax receivable |
$ | $ | ||||||
| Prepaid payroll |
||||||||
| Prepaid workers' compensation and liability insurance |
||||||||
| Prepaid licensing fees |
||||||||
| Workers' compensation insurance receivable |
||||||||
| Other (1) |
||||||||
| Total prepaid expenses and other current assets |
$ | $ | ||||||
| (1) |
Included $ |
Accrued expenses consisted of the following:
| June 30, 2025 |
December 31, 2024 |
|||||||
| (Amounts in Thousands) |
||||||||
| Accrued health benefits |
$ | $ | ||||||
| Accrued professional fees |
||||||||
| Accrued payroll and other taxes |
||||||||
| Other |
||||||||
| Total accrued expenses |
$ | $ | ||||||
7. ARPA Spending Plans
To mitigate the fiscal effects of the COVID-19 public health emergency, the American Rescue Plan Act of 2021 (“ARPA”) provided for a 10-percentage point increase in federal matching funds for Medicaid home and community-based services (“HCBS”) from April 1, 2021, through March 31, 2022, provided the states satisfied certain conditions. States were generally permitted to use the state funds equivalent to the additional federal funds through March 31, 2025, but CMS granted extensions to several states, permitting some state spending plans to continue until as late as mid-2026. States must use the monies attributable to this matching fund increase to supplement, not supplant, their level of state spending for the implementation of activities enhanced under the Medicaid HCBS in effect as of April 1, 2021.
HCBS spending plans for the additional matching funds vary by state, but common initiatives in which the Company is participating include those aimed at strengthening the provider workforce (e.g., efforts to recruit, retain, and train direct service providers). The Company is required to properly and fully document the use of such funds in reports to the state in which the funds originated. Funds may be subject to recoupment if not expended or if they are expended on non-approved uses.
During the three and six months ended June 30, 2025, the Company did not receive additional state funding provided by the ARPA. Of the total state funding received by the Company pursuant to the ARPA through June 30, 2025, the Company utilized $
8. Long-Term Debt
Long-term debt consisted of the following:
| June 30, 2025 | December 31, 2024 | |||||||
| (Amounts in Thousands) | ||||||||
| Revolving loan under the credit facility | $ | $ | ||||||
| Less unamortized issuance costs | ( | ) | ( | ) | ||||
| Long-term debt | $ | $ | ||||||
Amended and Restated Senior Secured Credit Facility
On October 31, 2018, the Company entered into the Amended and Restated Credit Agreement, with certain lenders and Capital One, National Association, as a lender and as agent for all lenders, as amended by the First Amendment to Amended and Restated Credit Agreement, dated as of September 12, 2019, as further amended by the Second Amendment to Amended and Restated Credit Agreement, dated as of July 30, 2021, as further amended by the Third Amendment to Amended and Restated Credit Agreement, dated as of April 26, 2023, and as further amended by the Fourth Amendment to Amended and Restated Credit Agreement, dated as of October 22, 2024 (as described below, the “Fourth Amendment”) (as amended, the “Credit Agreement”, as used throughout this Quarterly Report on Form 10-Q, “credit facility” shall mean the credit facility evidenced by the Credit Agreement). The credit facility consists of a $
On October 22, 2024, the Company entered into the Fourth Amendment to, among other things, (a) increase the Company’s revolving credit facility to an aggregate amount of $
Interest on the credit facility may be payable at (x) the sum of (i) an applicable margin ranging from
Addus HealthCare, Inc. (“Addus HealthCare”) is the borrower, and its parent, Holdings, and substantially all of Holdings’ subsidiaries are guarantors under this credit facility, and it is collateralized by a first priority security interest in all of the Company’s and the other credit parties’ current and future tangible and intangible assets, including the shares of stock of the borrower and subsidiaries. The Credit Agreement contains affirmative and negative covenants customary for credit facilities of this type, including limitations on the Company with respect to liens, indebtedness, guaranties, investments, distributions, mergers and acquisitions, and dispositions of assets. The availability of additional draws under this credit facility is conditioned, among other things, upon (after giving effect to such draws) the Total Net Leverage Ratio (as defined in the Credit Agreement) not exceeding 3.75:1.00. In certain circumstances, in connection with a Material Acquisition (as defined in the Credit Agreement), the Company can elect to increase its Total Net Leverage Ratio compliance covenant to 4.25:1.00 for the then current fiscal quarter and the three succeeding fiscal quarters.
The Company pays a fee ranging from
The Credit Agreement contains customary affirmative covenants regarding, among other things, the maintenance of records, compliance with laws, maintenance of permits, maintenance of insurance and property, and payment of taxes. The Credit Agreement also contains certain customary financial covenants and negative covenants that, among other things, include a requirement to maintain a minimum Interest Coverage Ratio (as defined in the Credit Agreement) and a requirement to stay below a maximum Total Net Leverage Ratio (as defined in the Credit Agreement). The Credit Agreement also contains restrictions on guarantees, indebtedness, liens, investments, and loans, subject to customary carve outs, a restriction on dividends (provided that Addus HealthCare may make distributions to the Company in an amount that does not exceed $
During the six months ended June 30, 2025, the Company did not draw on its credit facility and repaid $
As of June 30, 2025, the Company had a total of $
As of June 30, 2025, the Company was in compliance with all financial covenants under the Credit Agreement.
9. Income Taxes
The effective income tax rates were
For the three months ended June 30, 2025, the difference between our federal statutory and effective income tax rates was principally due to the inclusion of state taxes, non-deductible compensation and an excess tax expense, partially offset by the use of federal employment tax credits. For both the three months ended June 30, 2025 and 2024, the effective tax rates were inclusive of an excess tax expense and tax benefit of
10. Commitments and Contingencies
Legal Proceedings
From time to time, the Company is subject to legal and/or administrative proceedings incidental to its business.
It is the opinion of management that the outcome of pending legal and/or administrative proceedings will not have a material effect on the Company’s Unaudited Condensed Consolidated Balance Sheets and Unaudited Condensed Consolidated Statements of Income.
11. Segment Information
Operating segments are defined as components of a company that engage in business activities from which it may earn revenues and incur expenses, and for which separate financial information is available and is regularly reviewed by the Company’s CODM. The Company identifies its Chief Executive Officer and Chief Operating Officer together as CODMs to assess the performance of the individual segments and make decisions about resources to be allocated to the segments. The Company operates as a multi-state provider of three business segments providing in-home services.
In its personal care segment, the Company provides non-medical assistance with activities of daily living, primarily to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. In its hospice segment, the Company provides physical, emotional, and spiritual care for people who are terminally ill as well as related services for their families. In its home health segment, the Company provides services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational, and speech therapy.
The Company’s method for measuring profitability on each reportable segment basis is the same as those described in the summary of significant accounting policies and its CODMs frequently review the actual result to budget variance to allocate resources to the segment and assess its performance. Segment operating income consists of revenue generated by a segment, less the direct costs of service revenues and general and administrative expenses that are incurred directly by the segment. Unallocated general and administrative costs are those costs for functions performed in a centralized manner and therefore not attributable to a particular segment. These costs include accounting, finance, human resources, legal, information technology, corporate office support and facility costs and overall corporate management.
The CODMs do not review disaggregated assets by segment. The measure of segment assets is reported on the balance sheet as total consolidated assets.
The tables below set forth information about the Company’s reportable segments, along with the items necessary to reconcile the segment information to the totals reported in the accompanying Unaudited Condensed Consolidated Financial Statements.
| For the Three Months Ended June 30, 2025 | ||||||||||||||||
| (Amounts in Thousands) | ||||||||||||||||
| Personal Care | Hospice | Home Health | Total | |||||||||||||
| Net service revenues | $ | $ | $ | $ | ||||||||||||
| Direct service personnel | ||||||||||||||||
| General and administrative salaries, wages and benefits | ||||||||||||||||
| Other segment items 1 | ||||||||||||||||
| Segment operating income | ||||||||||||||||
| Segment reconciliation: | ||||||||||||||||
| Items not allocated at segment level: | ||||||||||||||||
| Other general and administrative expenses | ||||||||||||||||
| Depreciation and amortization | ||||||||||||||||
| Interest income | ( | ) | ||||||||||||||
| Interest expense | ||||||||||||||||
| Income before income taxes | $ | |||||||||||||||
| (1) | Other segment items include other costs for direct service personnel, office expense, licenses and taxes, communication, medical director fees, travel, and bad debt expense. |
| For the Three Months Ended June 30, 2024 | ||||||||||||||||
| (Amounts in Thousands) | ||||||||||||||||
| Personal Care | Hospice | Home Health | Total | |||||||||||||
| Net service revenues | $ | $ | $ | $ | ||||||||||||
| Direct service personnel | ||||||||||||||||
| General and administrative salaries, wages and benefits | ||||||||||||||||
| Other segment items 1 | ||||||||||||||||
| Segment operating income | ||||||||||||||||
| Segment reconciliation: | ||||||||||||||||
| Items not allocated at segment level: | ||||||||||||||||
| Other general and administrative expenses | ||||||||||||||||
| Depreciation and amortization | ||||||||||||||||
| Interest income | ( | ) | ||||||||||||||
| Interest expense | ||||||||||||||||
| Income before income taxes | $ | |||||||||||||||
| (1) | Other segment items include other costs for direct service personnel, office expense, licenses and taxes, communication, medical director fees, travel, and bad debt expense. |
| For the Six Months Ended June 30, 2025 | ||||||||||||||||
| (Amounts in Thousands) | ||||||||||||||||
| Personal Care | Hospice | Home Health | Total | |||||||||||||
| Net service revenues | $ | $ | $ | $ | ||||||||||||
| Direct service personnel | ||||||||||||||||
| General and administrative salaries, wages and benefits | ||||||||||||||||
| Other segment items 1 | ||||||||||||||||
| Segment operating income | ||||||||||||||||
| Segment reconciliation: | ||||||||||||||||
| Items not allocated at segment level: | ||||||||||||||||
| Other general and administrative expenses | ||||||||||||||||
| Depreciation and amortization | ||||||||||||||||
| Interest income | ( | ) | ||||||||||||||
| Interest expense | ||||||||||||||||
| Income before income taxes | $ | |||||||||||||||
| (1) | Other segment items include other costs for direct service personnel, office expense, licenses and taxes, communication, medical director fees, travel, and bad debt expense |
| For the Six Months Ended June 30, 2024 | ||||||||||||||||
| (Amounts in Thousands) | ||||||||||||||||
| Personal Care | Hospice | Home Health | Total | |||||||||||||
| Net service revenues | $ | $ | $ | $ | ||||||||||||
| Direct service personnel | ||||||||||||||||
| General and administrative salaries, wages and benefits | ||||||||||||||||
| Other segment items 1 | ||||||||||||||||
| Segment operating income | ||||||||||||||||
| Segment reconciliation: | ||||||||||||||||
| Items not allocated at segment level: | ||||||||||||||||
| Other general and administrative expenses | ||||||||||||||||
| Depreciation and amortization | ||||||||||||||||
| Interest income | ( | ) | ||||||||||||||
| Interest expense | ||||||||||||||||
| Income before income taxes | $ | |||||||||||||||
| (1) | Other segment items include other costs for direct service personnel, office expense, licenses and taxes, communication, medical director fees, travel, and bad debt expense |
12. Significant Payors
The Company’s revenue by payor type was as follows:
| Personal Care Segment |
For the Three Months Ended June 30, |
For the Six Months Ended June 30, |
||||||||||||||||||||||||||||||
| 2025 |
2024 |
2025 |
2024 |
|||||||||||||||||||||||||||||
| % of Segment |
% of Segment |
% of Segment |
% of Segment |
|||||||||||||||||||||||||||||
| Amount |
Net Service |
Amount |
Net Service |
Amount |
Net Service |
Amount |
Net Service |
|||||||||||||||||||||||||
| (in Thousands) |
Revenues |
(in Thousands) |
Revenues |
(in Thousands) |
Revenues |
(in Thousands) |
Revenues |
|||||||||||||||||||||||||
| State, local and other governmental programs |
$ | % | $ | % | $ | % | $ | % | ||||||||||||||||||||||||
| Managed care organizations |
||||||||||||||||||||||||||||||||
| Private pay |
||||||||||||||||||||||||||||||||
| Commercial insurance |
||||||||||||||||||||||||||||||||
| Other |
||||||||||||||||||||||||||||||||
| Total personal care segment net service revenues |
$ | % | $ | % | $ | % | $ | % | ||||||||||||||||||||||||
| Hospice Segment |
For the Three Months Ended June 30, |
For the Six Months Ended June 30, |
||||||||||||||||||||||||||||||
| 2025 |
2024 |
2025 |
2024 |
|||||||||||||||||||||||||||||
| % of Segment |
% of Segment |
% of Segment |
% of Segment |
|||||||||||||||||||||||||||||
| Amount |
Net Service |
Amount |
Net Service |
Amount |
Net Service |
Amount |
Net Service |
|||||||||||||||||||||||||
| (in Thousands) |
Revenues |
(in Thousands) |
Revenues |
(in Thousands) |
Revenues |
(in Thousands) |
Revenues |
|||||||||||||||||||||||||
| Medicare |
$ | % | $ | % | $ | % | $ | % | ||||||||||||||||||||||||
| Commercial insurance |
||||||||||||||||||||||||||||||||
| Managed care organizations |
||||||||||||||||||||||||||||||||
| Other |
||||||||||||||||||||||||||||||||
| Total hospice segment net service revenues |
$ | % | $ | % | $ | % | $ | % | ||||||||||||||||||||||||
| Home Health Segment |
For the Three Months Ended June 30, |
For the Six Months Ended June 30, |
||||||||||||||||||||||||||||||
| 2025 |
2024 |
2025 |
2024 |
|||||||||||||||||||||||||||||
| % of Segment |
% of Segment |
% of Segment |
% of Segment |
|||||||||||||||||||||||||||||
| Amount |
Net Service |
Amount |
Net Service |
Amount |
Net Service |
Amount |
Net Service |
|||||||||||||||||||||||||
| (in Thousands) |
Revenues |
(in Thousands) |
Revenues |
(in Thousands) |
Revenues |
(in Thousands) |
Revenues |
|||||||||||||||||||||||||
| Medicare |
$ | % | $ | % | $ | % | $ | % | ||||||||||||||||||||||||
| Managed care organizations |
||||||||||||||||||||||||||||||||
| State, local and other governmental programs (excluding Medicare) |
||||||||||||||||||||||||||||||||
| Other |
||||||||||||||||||||||||||||||||
| Total home health segment net service revenues |
$ | % | $ | % | $ | % | $ | % | ||||||||||||||||||||||||
The Company derives a significant amount of its revenue from its operations in Illinois, New Mexico, Ohio, Tennessee, and Texas. The percentages of segment revenue for each of these significant states and New York for the three and six months ended June 30, 2025 and 2024, respectively, were as follows:
| Personal Care Segment |
For the Three Months Ended June 30, |
For the Six Months Ended June 30, |
||||||||||||||||||||||||||||||
| 2025 |
2024 |
2025 |
2024 |
|||||||||||||||||||||||||||||
| % of Segment |
% of Segment |
% of Segment |
% of Segment |
|||||||||||||||||||||||||||||
| Amount |
Net Service |
Amount |
Net Service |
Amount |
Net Service |
Amount |
Net Service |
|||||||||||||||||||||||||
| (in Thousands) |
Revenues |
(in Thousands) |
Revenues |
(in Thousands) |
Revenues |
(in Thousands) |
Revenues |
|||||||||||||||||||||||||
| Illinois |
$ | % | $ | % | $ | % | $ | % | ||||||||||||||||||||||||
| New Mexico |
||||||||||||||||||||||||||||||||
| New York(1) |
( |
) | 46,833 | 11.1 | ||||||||||||||||||||||||||||
| Texas |
||||||||||||||||||||||||||||||||
| All other states |
||||||||||||||||||||||||||||||||
| Total personal care segment net service revenues |
$ | % | $ | % | $ | % | $ | % | ||||||||||||||||||||||||
| (1) |
As a result of changes and uncertainty in New York regarding the CDPAP, the Company determined that its New York personal care operations no longer fit its growth strategy and is divesting these operations. See Note 3 to the Notes to Unaudited Condensed Consolidated Financial Statements, Divestiture, for additional details regarding our divestiture. |
| Hospice Segment |
For the Three Months Ended June 30, |
For the Six Months Ended June 30, |
||||||||||||||||||||||||||||||
| 2025 |
2024 |
2025 |
2024 |
|||||||||||||||||||||||||||||
| % of Segment |
% of Segment |
% of Segment |
% of Segment |
|||||||||||||||||||||||||||||
| Amount |
Net Service |
Amount |
Net Service |
Amount |
Net Service |
Amount |
Net Service |
|||||||||||||||||||||||||
| (in Thousands) |
Revenues |
(in Thousands) |
Revenues |
(in Thousands) |
Revenues |
(in Thousands) |
Revenues |
|||||||||||||||||||||||||
| Ohio |
$ | % | $ | % | $ | % | $ | % | ||||||||||||||||||||||||
| Illinois |
||||||||||||||||||||||||||||||||
| New Mexico |
||||||||||||||||||||||||||||||||
| All other states |
||||||||||||||||||||||||||||||||
| Total hospice segment net service revenues |
$ | % | $ | % | $ | % | $ | % | ||||||||||||||||||||||||
| Home Health Segment |
For the Three Months Ended June 30, |
For the Six Months Ended June 30, |
||||||||||||||||||||||||||||||
| 2025 |
2024 |
2025 |
2024 |
|||||||||||||||||||||||||||||
| % of Segment |
% of Segment |
% of Segment |
% of Segment |
|||||||||||||||||||||||||||||
| Amount |
Net Service |
Amount |
Net Service |
Amount |
Net Service |
Amount |
Net Service |
|||||||||||||||||||||||||
| (in Thousands) |
Revenues |
(in Thousands) |
Revenues |
(in Thousands) |
Revenues |
(in Thousands) |
Revenues |
|||||||||||||||||||||||||
| New Mexico |
$ | % | $ | % | $ | % | $ | % | ||||||||||||||||||||||||
| Illinois |
||||||||||||||||||||||||||||||||
| Tennessee |
||||||||||||||||||||||||||||||||
| Total home health segment net service revenues |
$ | % | $ | % | $ | % | $ | % | ||||||||||||||||||||||||
A substantial portion of the Company’s revenue and accounts receivable are derived from services performed for federal, state, and local governmental agencies. The personal care segment derives a significant amount of its net service revenues in Illinois, which represented
The related receivables due from the Illinois Department on Aging represented
13. Subsequent Events
On August 1, 2025, the Company completed the acquisition of Helping Hands Home Care Service, Inc., a Pennsylvania corporation (“Helping Hands”), for approximately $
On July 4, 2025, H.R. 1, commonly known as the “One Big Beautiful Bill Act” (the “OBBBA”), was enacted into law. The OBBBA includes several provisions, including the permanent extension of several business tax benefits originally introduced under the 2017 Tax Cuts and Jobs Act. The Company is currently evaluating the impact of the legislation on its condensed consolidated financial statements.
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
You should read the following discussion together with our unaudited condensed consolidated financial statements and the related notes included elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements about our business and operations. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words like “believes,” “belief,” “expects,” “plans,” “anticipates,” “intends,” “projects,” “estimates,” “may,” “might,” “would,” “should,” and similar expressions are intended to be forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. These statements are based on the beliefs and assumptions of our management based on information currently available to management. Such forward-looking statements are subject to risks, uncertainties and other important factors that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to: the impact of macroeconomic conditions, including significant global inflation and interest rates, legislative and political developments, including any hold on or cancellation of congressionally authorized spending or interruptions in the distribution of government funds, trade policies and tensions, including changes in, or the imposition of, tariffs and/or trade barriers and the economic impacts, volatility and uncertainty resulting therefrom, and the potential adverse effects of current conditions; business disruptions due to inclement weather, natural disasters, acts of terrorism, military conflicts, pandemics, civil insurrection or social unrest; changes in operational and reimbursement processes and payment structures at the state or federal levels; changes in Medicaid, Medicare, other government program and managed care organizations’ policies and payment rates, and the timeliness of reimbursements received under government programs; the implementation of new, and possible changes to, existing, federal and state laws or regulations, or our failure to comply with such laws or regulations or comply on a timely basis; the impact of decisions of the U.S. Supreme Court regarding the actions of federal agencies; changes in presidential administrations; changes in the structure and administration of, and funding for, federal and state agencies and programs; competition in the healthcare industry; the geographical concentration of our operations; changes in the case mix of consumers and payment methodologies; operational changes resulting from the assumption by managed care organizations of responsibility for managing and paying for our services to consumers; the nature and success of future financial and/or delivery system reforms; changes in estimates and judgments associated with critical accounting policies; our ability to maintain or establish new referral sources; our ability to renew significant agreements or groups of agreements; our ability to attract and retain qualified personnel; federal, state and city minimum wage pressure, including any failure of any governmental entity to enact a minimum wage offset and/or the timing of any such enactment; changes in payments and covered services due to overall economic conditions and deficit reduction measures by federal and state governments, and our expectations regarding these changes; cost containment initiatives undertaken by federal and state governmental and other third-party payors; our ability to access financing through the capital and credit markets; our ability to meet debt service requirements and comply with covenants in debt agreements; our ability to integrate and manage our information systems; any security breaches, cyber-attacks, loss of data, or cybersecurity threats or incidents, and any actual or perceived failures to comply with legal requirements related to the privacy of confidential consumer data and other sensitive information; the size and growth of the markets for our services, including our expectations regarding the markets for our services; eligibility standards and coverage limits imposed through legislation or by governmental agencies or other third-party payors; the potential for litigation, audits, and investigations; discretionary determinations by government officials; our ability to successfully implement our business model to grow our business; our ability to continue identifying, pursuing, consummating, and integrating acquisition opportunities and expanding into new geographic markets; the impact of acquisitions and dispositions on our business, including the potential inability to realize the benefits of potential acquisitions; the effectiveness, quality, and cost of our services; our ability to successfully execute our growth strategy; changes in tax rates; and various other matters, many of which are beyond our control. In addition, these forward-looking statements are subject to the risk factors set forth in Part I, Item 1A of our Annual Report on Form 10-K for the period ended December 31, 2024, filed with the SEC on February 25, 2025. You should carefully review all of these factors. Moreover, our business may be materially adversely affected by factors that are not currently known to us, by factors that we currently consider immaterial or by factors that are not specific to us, such as general economic conditions. These forward-looking statements were based on information, plans, and estimates at the date of this report, and we assume no obligation to update any forward-looking statements to reflect changes in underlying assumptions or factors, new information, future events or other changes, except as may be required by law.
Overview
We are a home care services provider operating three segments: personal care, hospice, and home health. Our services are principally provided in-home under agreements with federal, state, and local government agencies, managed care organizations, commercial insurers, and private individuals. Our consumers are predominantly “dual eligible,” meaning they are eligible to receive both Medicare and Medicaid benefits. Managed care organizations accounted for 35.6% and 34.2% of our net service revenues during the three months ended June 30, 2025 and 2024, respectively, and 35.6% and 34.2% of our net service revenues during the six months ended June 30, 2025 and 2024, respectively.
A summary of certain consolidated financial results is provided in the table below.
| For the Three Months Ended June 30, |
For the Six Months Ended June 30, |
|||||||||||||||
| 2025 |
2024 |
2025 |
2024 |
|||||||||||||
| Net service revenues by segment: |
(Amounts in Thousands) |
(Amounts in Thousands) |
||||||||||||||
| Personal care |
$ | 269,183 | $ | 212,817 | $ | 527,469 | $ | 420,820 | ||||||||
| Hospice |
62,212 | 56,030 | 123,649 | 111,893 | ||||||||||||
| Home health |
18,048 | 18,075 | 36,033 | 34,955 | ||||||||||||
| Total net service revenue |
$ | 349,443 | $ | 286,922 | $ | 687,151 | $ | 567,668 | ||||||||
| Net income |
$ | 22,052 | $ | 18,079 | $ | 43,280 | $ | 33,909 | ||||||||
As of June 30, 2025, we provided our services in 23 states through 260 offices. We served approximately 78,000 and 70,000 discrete individuals, respectively, during the six months ended June 30, 2025 and 2024. Our personal care segment also includes staffing services, with clients including assisted living facilities, nursing homes, and hospice facilities.
Acquisitions
In addition to our organic growth, we have grown through acquisitions that have expanded our presence in current markets, with the goal of having all three levels of in-home care in our markets or facilitating our entry into new markets where in-home care has been moving to managed care organizations or that present other strategic opportunities.
On March 9, 2024, we completed our acquisition of the operations of Upstate Home Care Solutions (“Upstate”) for $0.4 million, with funding provided by available cash. With the purchase of Upstate, the Company expanded its personal care segment in South Carolina.
On December 2, 2024, we completed the acquisition of the personal care business of Curo Health Services, LLC, a Delaware limited liability company that does business as Gentiva, consisting of certain equity interests and assets and liabilities (collectively, the “Gentiva Acquisition”) for approximately $350.6 million, with funding primarily provided by drawing on the Company’s revolving credit facility and a portion of the net proceeds of the Company’s public offering of common stock (the “Public Offering”). With the Gentiva Acquisition, the Company expanded its services within its personal care segment in Arizona, Arkansas, California, and North Carolina, and entered the market in Missouri and Texas. The home health segment also was expanded in Tennessee.
On January 1, 2025, the Company completed the Jacksonville Acquisition for approximately $0.8 million, with funding provided by available cash. With the Jacksonville Acquisition, the Company expanded its personal care segment in Florida and recorded goodwill of $0.8 million.
On March 1, 2025, the Company completed the Great Lakes Acquisition for $2.6 million, with funding provided by available cash. With the Great Lakes Acquisition, the Company expanded its personal care segment in Michigan and recognized goodwill in its personal care segment of $2.6 million.
New York Asset Sale
Effective May 20, 2024, we entered into the New York Asset Sale. The Company entered into a consulting agreement with the purchaser, as the transfer of clients and caregivers and payment for assets pursuant to the New York Asset Sale is occurring over time as regulatory approvals are received, coordination of the transfer of clients and caregivers occurs, and the change of control takes place. In connection with this transaction, the Company ceased operations in New York. See Note 3 to the Notes to Unaudited Condensed Consolidated Financial Statements, Divesture, for additional details regarding our divestiture.
Recruiting
As the labor market continues to be tight and unemployment remains at low levels, the competition for new caregivers, including skilled healthcare staff, and support staff continues to be significant. In addition, the United States economy continues to experience inflationary pressures. To the extent that we continue to experience a shortage of caregivers, it may hinder our ability to fully meet the continuing demand for both our non-clinical and clinical services.
Revenue by Payor and Significant States
Our payors are principally federal, state, and local governmental agencies and managed care organizations. The federal, state, and local programs under which the agencies operate are subject to legislative and budgetary changes and other risks that can influence reimbursement rates. We are experiencing a transition of business from government payors to managed care organizations, which we believe aligns with our emphasis on coordinated care and the reduction of the need for acute care.
Our revenue by payor and significant states by segment were as follows:
| Personal Care Segment |
For the Three Months Ended June 30, |
For the Six Months Ended June 30, |
||||||||||||||||||||||||||||||
| 2025 |
2024 |
2025 |
2024 |
|||||||||||||||||||||||||||||
| % of Segment |
% of Segment |
% of Segment |
% of Segment |
|||||||||||||||||||||||||||||
| Amount |
Net Service |
Amount |
Net Service |
Amount |
Net Service |
Amount |
Net Service |
|||||||||||||||||||||||||
| (in Thousands) |
Revenues |
(in Thousands) |
Revenues |
(in Thousands) |
Revenues |
(in Thousands) |
Revenues |
|||||||||||||||||||||||||
| State, local and other governmental programs |
$ | 138,506 | 51.4 | % | $ | 113,002 | 53.1 | % | $ | 271,410 | 51.4 | % | $ | 220,756 | 52.5 | % | ||||||||||||||||
| Managed care organizations |
121,900 | 45.3 | 94,135 | 44.2 | 238,907 | 45.3 | 188,411 | 44.8 | ||||||||||||||||||||||||
| Private pay |
7,292 | 2.7 | 3,689 | 1.7 | 14,268 | 2.7 | 7,595 | 1.8 | ||||||||||||||||||||||||
| Commercial insurance |
1,334 | 0.5 | 1,467 | 0.7 | 2,494 | 0.5 | 2,953 | 0.7 | ||||||||||||||||||||||||
| Other |
151 | 0.1 | 524 | 0.3 | 390 | 0.1 | 1,105 | 0.2 | ||||||||||||||||||||||||
| Total personal care segment net service revenues |
$ | 269,183 | 100.0 | % | $ | 212,817 | 100.0 | % | $ | 527,469 | 100.0 | % | $ | 420,820 | 100.0 | % | ||||||||||||||||
| Illinois |
115,226 | 42.8 | % | 110,774 | 52.1 | % | 226,640 | 43.0 | % | 218,349 | 51.9 | % | ||||||||||||||||||||
| New Mexico |
28,987 | 10.8 | 28,644 | 13.5 | 57,292 | 10.9 | 57,611 | 13.7 | ||||||||||||||||||||||||
| New York |
(59 | ) | — | 23,299 | 10.9 | 214 | — | 46,833 | 11.1 | |||||||||||||||||||||||
| Texas |
52,464 | 19.5 | — | — | 102,324 | 19.4 | — | — | ||||||||||||||||||||||||
| All other states |
72,565 | 26.9 | 50,100 | 23.5 | 140,999 | 26.7 | 98,027 | 23.3 | ||||||||||||||||||||||||
| Total personal care segment net service revenues |
$ | 269,183 | 100.0 | % | $ | 212,817 | 100.0 | % | $ | 527,469 | 100.0 | % | $ | 420,820 | 100.0 | % | ||||||||||||||||
| Hospice Segment |
For the Three Months Ended June 30, |
For the Six Months Ended June 30, |
||||||||||||||||||||||||||||||
| 2025 |
2024 |
2025 |
2024 |
|||||||||||||||||||||||||||||
| % of Segment |
% of Segment |
% of Segment |
% of Segment |
|||||||||||||||||||||||||||||
| Amount |
Net Service |
Amount |
Net Service |
Amount |
Net Service |
Amount |
Net Service |
|||||||||||||||||||||||||
| (in Thousands) |
Revenues |
(in Thousands) |
Revenues |
(in Thousands) |
Revenues |
(in Thousands) |
Revenues |
|||||||||||||||||||||||||
| Medicare |
$ | 57,846 | 93.0 | % | $ | 51,122 | 91.2 | % | $ | 114,638 | 92.7 | % | $ | 101,774 | 91.0 | % | ||||||||||||||||
| Commercial insurance |
1,997 | 3.2 | 2,844 | 5.1 | 4,375 | 3.5 | 5,978 | 5.3 | ||||||||||||||||||||||||
| Managed care organizations |
2,001 | 3.2 | 1,880 | 3.4 | 4,029 | 3.3 | 3,697 | 3.3 | ||||||||||||||||||||||||
| Other |
368 | 0.6 | 184 | 0.3 | 607 | 0.5 | 444 | 0.4 | ||||||||||||||||||||||||
| Total hospice segment net service revenues |
$ | 62,212 | 100.0 | % | $ | 56,030 | 100.0 | % | $ | 123,649 | 100.0 | % | $ | 111,893 | 100.0 | % | ||||||||||||||||
| Ohio |
$ | 23,204 | 37.3 | % | $ | 20,633 | 36.8 | % | $ | 46,391 | 37.5 | % | $ | 40,869 | 36.5 | % | ||||||||||||||||
| Illinois |
14,419 | 23.2 | 13,003 | 23.2 | 28,983 | 23.4 | 25,255 | 22.6 | ||||||||||||||||||||||||
| New Mexico |
8,184 | 13.2 | 6,895 | 12.3 | 16,097 | 13.0 | 14,410 | 12.9 | ||||||||||||||||||||||||
| All other states |
16,405 | 26.3 | 15,499 | 27.7 | 32,178 | 26.1 | 31,359 | 28.0 | ||||||||||||||||||||||||
| Total hospice segment net service revenues |
$ | 62,212 | 100.0 | % | $ | 56,030 | 100.0 | % | $ | 123,649 | 100.0 | % | $ | 111,893 | 100.0 | % | ||||||||||||||||
| Home Health Segment |
For the Three Months Ended June 30, |
For the Six Months Ended June 30, |
||||||||||||||||||||||||||||||
| 2025 |
2024 |
2025 |
2024 |
|||||||||||||||||||||||||||||
| % of Segment |
% of Segment |
% of Segment |
% of Segment |
|||||||||||||||||||||||||||||
| Amount |
Net Service |
Amount |
Net Service |
Amount |
Net Service |
Amount |
Net Service |
|||||||||||||||||||||||||
| (in Thousands) |
Revenues |
(in Thousands) |
Revenues |
(in Thousands) |
Revenues |
(in Thousands) |
Revenues |
|||||||||||||||||||||||||
| Medicare |
$ | 12,517 | 69.4 | % | $ | 12,517 | 69.3 | % | $ | 25,094 | 69.7 | % | $ | 24,180 | 69.2 | % | ||||||||||||||||
| Managed care organizations |
4,264 | 23.6 | 4,676 | 25.9 | 8,072 | 22.4 | 9,076 | 26.0 | ||||||||||||||||||||||||
| State, local and other governmental programs (excluding Medicare) |
796 | 4.4 | 44 | 0.2 | 1,884 | 5.2 | 70 | 0.2 | ||||||||||||||||||||||||
| Other |
471 | 2.6 | 838 | 4.6 | 983 | 2.7 | 1,629 | 4.6 | ||||||||||||||||||||||||
| Total home health segment net service revenues |
$ | 18,048 | 100.0 | % | $ | 18,075 | 100.0 | % | $ | 36,033 | 100.0 | % | $ | 34,955 | 100.0 | % | ||||||||||||||||
| New Mexico |
$ | 8,737 | 48.4 | % | $ | 8,300 | 45.9 | % | $ | 17,292 | 48.0 | % | $ | 16,077 | 46.0 | % | ||||||||||||||||
| Illinois |
1,989 | 11.0 | 3,042 | 16.8 | 3,921 | 10.9 | 5,984 | 17.1 | ||||||||||||||||||||||||
| Tennessee |
7,322 | 40.6 | 6,733 | 37.3 | 14,820 | 41.1 | 12,894 | 36.9 | ||||||||||||||||||||||||
| Total home health segment net service revenues |
$ | 18,048 | 100.0 | % | $ | 18,075 | 100.0 | % | $ | 36,033 | 100.0 | % | $ | 34,955 | 100.0 | % | ||||||||||||||||
The personal care segment derives a significant amount of its net service revenues in Illinois, which represented 33.0% and 38.6% of our net service revenues for the three months ended June 30, 2025 and 2024, respectively, and accounted for 33.0% and 38.5% of our net service revenues for the six months ended June 30, 2025 and 2024, respectively.
A significant amount of our net service revenues are derived from one payor, the Illinois Department on Aging, the largest payor program for our Illinois personal care operations, which accounted for 18.6% and 21.1% of our net service revenues for the three months ended June 30, 2025 and 2024, respectively, and accounted for 18.6% and 20.9% of our net service revenues for the six months ended June 30, 2025 and 2024, respectively.
Changes in Illinois Reimbursement
The Illinois Medicaid omnibus legislation passed in June 2023 included an increase in hourly rates for in-home care services to $28.07, which took effect on January 1, 2024 and required a minimum wage rate of $17.00 per hour. CMS approved an amendment to the Illinois HCBS Waiver for Persons Who are Elderly, which included the rate increase for in-home care services to $28.07, effective January 1, 2024.
The Illinois fiscal year 2025 budget included an increase in hourly rates for in-home care services to $29.63, effective January 1, 2025, and required a minimum wage of $18.00 per hour for direct service workers. CMS approved an amendment to Illinois’ Persons Who are Elderly waiver program that included this rate increase, effective January 1, 2025.
The Illinois fiscal year 2026 budget includes an increase in hourly rates for in-home care services to $30.80, to take effect January 1, 2026, subject to standard federal approval. This rate sustains a minimum wage of $18.75 per hour for direct service workers.
The City of Chicago requires the Chicago minimum wage to be adjusted annually based on increases in the Consumer Price Index (“CPI”), subject to a cap and other requirements. Effective July 1, 2025, the rate was adjusted to $16.60 based on the increase in the CPI.
Our business will benefit from the rate increases noted above as planned for 2025, but there is no assurance that there will be additional rate increases in Illinois for fiscal years beyond fiscal year 2025 to offset increases to minimum wage, and our financial performance will be adversely impacted for any periods in which an additional offsetting reimbursement rate increase is not in effect.
Changes in Texas Reimbursement
The Texas fiscal year 2026 budget includes an increase in hourly rates to $17.13 for in-home care services effective September 1, 2025, subject to standard federal approval.
Impact of Changes in Medicare and Medicaid Reimbursement
Hospice
Hospice services provided to Medicare beneficiaries are paid under the Medicare Hospice Prospective Payment System, under which CMS sets a daily rate for each day a patient is enrolled in the hospice benefit. The daily rate depends on the level of care provided to a patient (routine home care, continuous home care, inpatient respite care, or general inpatient care). Daily rates are adjusted for factors such as area wage levels. CMS updates hospice payment rates each federal fiscal year. Effective October 1, 2024, CMS increased hospice payment rates by 2.9%. This reflects a 3.4% market basket increase and a negative 0.5 percentage point productivity adjustment. Hospices that do not satisfy quality reporting requirements are subject to a 4-percentage point reduction to the market basket update.
Overall payments made by Medicare to each hospice provider number are subject to an inpatient cap and an aggregate cap. The inpatient cap limits the number of days of inpatient care for which Medicare will pay to no more than 20% of total patient care days. Days in excess of the limitation are paid at the routine home care rate. The aggregate cap limits the total Medicare reimbursement that a hospice may receive in a cap year (typically the federal fiscal year) based on an annual per-beneficiary cap amount, which is set each federal fiscal year, and the number of Medicare patients served. The per-beneficiary cap amount was updated to $34,465.34 for federal fiscal year 2025. If a hospice’s Medicare payments exceed its inpatient or aggregate caps, it must repay Medicare the excess amount.
Home Health
Home health services provided to Medicare beneficiaries are paid under the Medicare Home Health Prospective Payment System (“HHPPS”), which uses national, standardized 30-day period payment rates for periods of care that meet a certain threshold of home health visits (periods of care that do not meet the visit threshold are paid a per-visit payment rate for the discipline providing care). Although payment is made for each 30-day period, the HHPPS permits continuous 60-day certification periods through which beneficiaries are verified as eligible for the home health benefit. The daily home health payment rate is adjusted for case-mix and area wage levels. CMS uses the Patient-Driven Groupings Model (“PDGM”) as the case-mix classification model to place periods of care into payment categories, classifying patients based on clinical characteristics and their resource needs. An outlier adjustment may be paid for periods of care where costs exceed a specific threshold amount.
CMS updates the HHPPS payment rates each calendar year. For calendar year 2025, CMS estimates that Medicare payments to home health agencies will increase by 0.5%. This is based on a home health payment update percentage of 2.7%, which reflects a 3.2% market basket update, reduced by a productivity adjustment of 0.5 percentage points, and an estimated 1.8% decrease associated with the transition to the PDGM, among other changes. Home health providers that do not comply with quality data reporting requirements are subject to a 2-percentage point reduction to their market basket update. In addition, Medicare requires home health agencies to submit a one-time Notice of Admission (“NOA”) for each patient that establishes that the beneficiary is under a Medicare home health period of care. Failure to submit the NOA within five calendar days from the start of care will result in a reduction to the 30-day period payment amount for each day from the start of care date until the date the NOA is submitted.
Under the nationwide Home Health Value-Based Purchasing (“HHVBP”) Model, home health agencies receive increases or decreases to their Medicare fee-for-service payments of up to 5% based on performance against specific quality measures relative to the performance of other home health providers. Data collected in each performance year will impact Medicare payments two years later.
In certain states, payment of claims may be impacted by the Review Choice Demonstration for Home Health Services, a program intended to identify and prevent fraud, reduce the number of Medicare appeals and improve provider compliance with Medicare program requirements. The program is currently limited to home health agencies in Illinois, Ohio, Oklahoma, North Carolina, Florida, and Texas. Providers in states subject to the Review Choice Demonstration for Home Health Services may initially select either pre-claim review or post-payment review. Home health agencies that maintain high compliance levels are eligible for additional options that may be less burdensome. This program has not had a material impact on our results of operations or financial position.
CMS Final Rule: “Ensuring Access to Medicaid Services”
In May 2024, CMS finalized a rule intended to improve access to services and quality of care for Medicaid beneficiaries across fee-for-service and managed care delivery systems. The final rule includes significant provisions related to HCBS, including the “80/20” or “payment adequacy” requirement, which will require states to ensure by mid-2030 that at least 80% of all Medicaid payments a provider receives for homemaker, home health aide, and personal care services, less certain excluded costs, under specified programs are spent on total compensation (including benefits) for direct care workers furnishing these services, rather than administrative overhead or profit, subject to limited exceptions. The final rule includes several other measures intended to promote transparency and enhance quality and access to services, including a variety of reporting requirements for states. Given the long implementation period and the likelihood of further changes as a result of litigation, administration and congressional changes, further rule-making and state changes in response to the final rule, it is premature to predict the ultimate impact of the final rule on our business.
Developments in Public Policy
The outcome of the 2024 federal election increased regulatory uncertainty and the potential for significant policy changes. President Trump has issued executive orders that impact or may impact the healthcare industry, including an order establishing a presidential advisory commission, the Department of Government Efficiency (“DOGE”), focused on restructuring and streamlining government agencies and reducing or eliminating regulations and federal government programs and other expenditures. In March 2025, the Department of Health and Human Services (“HHS”) announced a significant restructuring in accordance with the President’s DOGE Workforce Optimization Initiative. The restructuring will reduce the HHS workforce and consolidate divisions of HHS, including integrating some functions of the Administration for Community Living, which administers programs that support older adults, into other HHS agencies. HHS also announced a change in its policy on public participation in rulemaking that may negatively affect the ability of industry participants to receive advance notice of and offer feedback on some policy changes. In addition, recent actions by the presidential administration have resulted in holds on or cancellations of congressionally authorized spending as well as interruptions in the distribution of governmental funds.
Home care and other healthcare providers may be significantly impacted by changes to the Medicaid program, including changes resulting from legislation and administrative actions at the federal and state levels. Federal actions may impact funding for, or the structure of, the Medicaid program, including through changes to Medicaid waiver programs, and may shape provider reimbursement rates, eligibility and coverage policies, and other aspects of state Medicaid programs. For example, the OBBBA includes policy changes that are expected to eventually result in significant cuts to federal healthcare spending, including significant changes to the Medicaid program, if fully implemented as enacted. The OBBBA limits eligibility for Medicaid through work requirements for some populations, reduces federal Medicaid funding and expands cost-sharing obligations for certain enrollees. Among other changes, the law makes significant changes to Medicaid financing mechanisms, including restrictions on provider tax arrangements that are intended to reduce the federal matching funds received by state Medicaid programs. In addition, the OBBBA, if implemented as enacted, would require eligibility redeterminations at least every six months for individuals covered under Medicaid expansion, with state compliance required by December 31, 2026. The law also would eventually prohibit states from establishing new provider taxes or increasing rates of existing provider taxes while also limiting the structure of such taxes. Future Medicaid reform initiatives at the federal and state levels may result in further reductions to Medicaid expenditures and involve additional administrative changes. Reduced funding for Medicaid or other changes to Medicaid programs, including Medicaid waiver programs could put pressure on state budgets and result in reductions to Medicaid payments, scope of coverage and enrollment. Such reductions could, in turn, affect our reimbursements for services rendered. We expect the impact of the OBBBA on the home care business will be less significant than the impact on other healthcare businesses.
The federal deficit and other federal and state budgetary pressures affect government healthcare program expenditures, and we anticipate that these effects will continue. For example, the OBBBA is expected to decrease federal healthcare spending, particularly with respect to Medicaid, and is generally expected to have a significant impact on state budgets, which may result in state-level changes such as reductions to the scope of covered services or tax increases. In addition, the OBBBA increases the federal budget deficit in a manner that triggers a statutorily mandated sequestration under the Pay-As-You-Go Act of 2010. As a result, a Medicare spending reduction of up to 4% is required to take effect in early 2026, absent congressional action. These reductions would be in addition to the payment reductions required by the Budget Control Act of 2011 and subsequent legislation, which are currently set to continue through the first ten months of federal fiscal year 2032. It is possible that future deficit reduction legislation will impose additional spending reductions.
Components of our Statements of Income
Net Service Revenues
We generate net service revenues by providing our services directly to consumers and primarily on an hourly basis in our personal care segment, on a daily basis in our hospice segment, and on an episodic basis in our home health segment. We receive payment for providing such services from our private consumers and payors, including federal, state, and local governmental agencies, managed care organizations, and commercial insurers.
In our personal care segment, net service revenues are principally provided based on authorized hours, determined by the relevant agency, at an hourly rate, which is either contractual or fixed by legislation, and are recognized at the time services are rendered. In our hospice segment, net service revenues are provided based on daily rates for each of the levels of care and are recognized as services are provided. In our home health segment, net service revenues are based on an episodic basis at a stated rate and recognized based on the number of days elapsed during a period of care within the reporting period. We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record revenues.
Cost of Service Revenues
We incur direct care wages, payroll taxes, and benefit-related costs in connection with providing our services. We also provide workers’ compensation and general liability coverage for our employees. Employees are also reimbursed for their travel time and related travel costs in certain instances.
General and Administrative Expenses
Our general and administrative expenses include our costs for operating our network of local agencies and our administrative offices. Our agency expenses consist of costs for supervisory personnel, our community care supervisors, and office administrative costs. Personnel costs include wages, payroll taxes, and employee benefits. Facility costs include rents, utilities, and postage, telephone, and office expenses. Our corporate and support center expenses include costs for accounting, information systems, human resources, billing and collections, contracting, marketing, and executive leadership. These expenses consist of compensation, including stock-based compensation, payroll taxes, employee benefits, legal, accounting and other professional fees, travel, general insurance, rents, provision for doubtful accounts, and related facility costs. Expenses related to streamlining our operations such as costs related to terminated employees, termination of professional services relationships, other contract termination costs, and asset write-offs are also included in general and administrative expenses.
Depreciation and Amortization Expenses
Depreciable assets consist principally of furniture and equipment, network administration and telephone equipment, and operating system software. Depreciable and leasehold assets are depreciated or amortized on a straight-line method over their useful lives or, if less and if applicable, their lease terms. We amortize our intangible assets with finite lives, consisting of customer and referral relationships, trade names, trademarks, and non-competition agreements, using straight line or accelerated methods based upon their estimated useful lives.
Interest Expense
Interest expense is reported when incurred and principally consists of interest and unused credit line fees on the credit facility.
Income Tax Expense
All of our income is from domestic sources. We incur state and local taxes in states in which we operate. The effective income tax rates were 26.4% and 26.3% for the three months ended June 30, 2025 and 2024, respectively. The effective income tax rates were 24.0% and 26.0% for the six months ended June 30, 2025 and 2024, respectively, compared to our federal statutory rate of 21%. The difference between our federal statutory and effective income tax rates was principally due to the inclusion of state taxes, non-deductible compensation, excess tax expense or benefit and the use of federal employment tax credits.
Results of Operations — Consolidated
Three Months Ended June 30, 2025 Compared to Three Months Ended June 30, 2024
The following table sets forth our unaudited condensed consolidated results of operations.
| For the Three Months Ended June 30, |
||||||||||||||||||||||||
| 2025 |
2024 |
Change |
||||||||||||||||||||||
| % Of |
% Of |
|||||||||||||||||||||||
| Net Service |
Net Service |
|||||||||||||||||||||||
| Amount |
Revenues |
Amount |
Revenues |
Amount |
% | |||||||||||||||||||
| (Amounts in Thousands, Except Percentages) |
||||||||||||||||||||||||
| Net service revenues |
$ | 349,443 | 100.0 | % | $ | 286,922 | 100.0 | % | $ | 62,521 | 21.8 | % | ||||||||||||
| Cost of service revenues |
235,566 | 67.4 | 193,764 | 67.5 | 41,802 | 21.6 | ||||||||||||||||||
| Gross profit |
113,877 | 32.6 | 93,158 | 32.5 | 20,719 | 22.2 | ||||||||||||||||||
| General and administrative expenses |
77,077 | 22.1 | 63,576 | 22.2 | 13,501 | 21.2 | ||||||||||||||||||
| Depreciation and amortization |
3,913 | 1.1 | 3,401 | 1.2 | 512 | 15.1 | ||||||||||||||||||
| Total operating expenses |
80,990 | 23.2 | 66,977 | 23.3 | 14,013 | 20.9 | ||||||||||||||||||
| Operating income |
32,887 | 9.4 | 26,181 | 9.1 | 6,706 | 25.6 | ||||||||||||||||||
| Interest income |
(583 | ) | (0.2 | ) | (474 | ) | (0.2 | ) | (109 | ) | 23.0 | |||||||||||||
| Interest expense |
3,525 | 1.0 | 2,114 | 0.7 | 1,411 | 66.7 | ||||||||||||||||||
| Total interest expense, net |
2,942 | 0.9 | 1,640 | 0.6 | 1,302 | 79.4 | ||||||||||||||||||
| Income before income taxes |
29,945 | 8.6 | 24,541 | 8.6 | 5,404 | 22.0 | ||||||||||||||||||
| Income tax expense |
7,893 | 2.3 | 6,462 | 2.3 | 1,431 | 22.1 | ||||||||||||||||||
| Net income |
$ | 22,052 | 6.3 | % | $ | 18,079 | 6.3 | % | $ | 3,973 | 22.0 | % | ||||||||||||
Net service revenues increased by 21.8% to $349.4 million for the three months ended June 30, 2025 compared to $286.9 million for the three months ended June 30, 2024. Revenue increased by $56.4 million in our personal care segment, by $6.2 million in our hospice segment and remained constant at approximately $18.1 million in our home health segment during the three months ended June 30, 2025, compared to the same period in 2024. The increase in our personal care segment was primarily due to the completion of the Gentiva Acquisition on December 2, 2024. The increase in our hospice segment revenue was due to organic growth.
Gross profit, expressed as a percentage of net service revenues, increased to 32.6% for the three months ended June 30, 2025, compared to 32.5% for the same period in 2024 due to growth in our higher margin hospice segment and the New York Asset Sale.
General and administrative expenses increased to $77.1 million for the three months ended June 30, 2025, as compared to $63.6 million for the three months ended June 30, 2024. The increase in general and administrative expenses was primarily due to the Gentiva Acquisition that resulted in an increase in administrative employee wage, bonus, tax, and benefit costs of $9.0 million. General and administrative expenses, expressed as a percentage of net service revenues, decreased to 22.1% for the three months ended June 30, 2025, from 22.2% for the three months ended June 30, 2024.
Interest expense increased to $3.5 million for the three months ended June 30, 2025 from $2.1 million for the three months ended June 30, 2024. The increase in interest expense was primarily due to higher average outstanding borrowings held under our credit facility for the three months ended June 30, 2025,compared to the three months ended June 30, 2024.
All of our income is from domestic sources. We incur state and local taxes in states in which we operate. The effective income tax rate was 26.4% and 26.3% for the three months ended June 30, 2025 and 2024, respectively. Our higher effective income tax rate for the three months ended June 30, 2025, was principally due to a higher excess tax expense with a higher benefit from the use of federal employment tax credits. For the three months ended June 30, 2025 and 2024, the excess tax expense and federal employment tax credits were 2.6% and 2.8%, respectively.
Six Months Ended June 30, 2025 Compared to Six Months Ended June 30, 2024
The following table sets forth our unaudited condensed consolidated results of operations.
| For the Six Months Ended June 30, |
||||||||||||||||||||||||
| 2025 |
2024 |
Change |
||||||||||||||||||||||
| % Of |
% Of |
|||||||||||||||||||||||
| Net Service |
Net Service |
|||||||||||||||||||||||
| Amount |
Revenues |
Amount |
Revenues |
Amount |
% | |||||||||||||||||||
| (Amounts in Thousands, Except Percentages) |
||||||||||||||||||||||||
| Net service revenues |
$ | 687,151 | 100.0 | % | $ | 567,668 | 100.0 | % | $ | 119,483 | 21.0 | % | ||||||||||||
| Cost of service revenues |
465,597 | 67.8 | 386,333 | 68.1 | 79,264 | 20.5 | ||||||||||||||||||
| Gross profit |
221,554 | 32.2 | 181,335 | 31.9 | 40,219 | 22.2 | ||||||||||||||||||
| General and administrative expenses |
150,297 | 21.9 | 124,639 | 22.0 | 25,658 | 20.6 | ||||||||||||||||||
| Depreciation and amortization |
7,856 | 1.1 | 6,870 | 1.2 | 986 | 14.4 | ||||||||||||||||||
| Total operating expenses |
158,153 | 23.0 | 131,509 | 23.2 | 26,644 | 20.3 | ||||||||||||||||||
| Operating income |
63,401 | 9.2 | 49,826 | 8.8 | 13,575 | 27.2 | ||||||||||||||||||
| Interest income |
(1,085 | ) | (0.2 | ) | (897 | ) | (0.2 | ) | (188 | ) | 21.0 | |||||||||||||
| Interest expense |
7,543 | 1.1 | 4,872 | 0.9 | 2,671 | 54.8 | ||||||||||||||||||
| Total interest expense, net |
6,458 | 0.9 | 3,975 | 0.7 | 2,483 | 62.5 | ||||||||||||||||||
| Income before income taxes |
56,943 | 8.3 | 45,851 | 8.1 | 11,092 | 24.2 | ||||||||||||||||||
| Income tax expense |
13,663 | 2.0 | 11,942 | 2.1 | 1,721 | 14.4 | ||||||||||||||||||
| Net income |
$ | 43,280 | 6.3 | % | $ | 33,909 | 6.0 | % | $ | 9,371 | 27.6 | % | ||||||||||||
Net service revenues increased by 21.0% to $687.2 million for the six months ended June 30, 2025 compared to $567.7 million for the six months ended June 30, 2024. Revenue increased by $106.6 million in our personal care segment, by $11.8 million in our hospice segment and by $1.1 million in our home health segment during the six months ended June 30, 2025, compared to the same period in 2024. The increase in our personal care and home health segments was primarily due to the completion of the Gentiva Acquisition on December 2, 2024. The increase in our hospice segment revenue was due to organic growth.
Gross profit, expressed as a percentage of net service revenues, increased to 32.2% for the six months ended June 30, 2025, compared to 31.9% for the same period in 2024 due to growth in hospice segment and the New York Asset Sale.
General and administrative expenses increased to $150.3 million for the six months ended June 30, 2025, as compared to $124.6 million for the six months ended June 30, 2024. The increase in general and administrative expenses was primarily due to the Gentiva Acquisition that resulted in an increase in administrative employee wage, bonus, tax, and benefit costs of $19.5 million. General and administrative expenses, expressed as a percentage of net service revenues, decreased to 21.9% for the six months ended June 30, 2025, from 22.0% for the six months ended June 30, 2024.
Interest expense increased to $7.5 million for the six months ended June 30, 2025 from $4.9 million for the six months ended June 30, 2024. The increase in interest expense was primarily due to higher average outstanding borrowings held under our credit facility for the six months ended June 30, 2025, compared to the six months ended June 30, 2024.
All of our income is from domestic sources. We incur state and local taxes in states in which we operate. The effective income tax rate was 24.0% and 26.0% for the six months ended June 30, 2025 and 2024, respectively. Our lower effective income tax rate for the six months ended June 30, 2025, was principally due to a higher excess tax benefit with a higher benefit from the use of federal employment tax credits. For the six months ended June 30, 2025 and 2024, the excess tax benefit and federal employment tax credits were 4.8% and 3.1%, respectively.
Results of Operations – Segments
The following tables and related analysis summarize our operating results and business metrics by segment:
Personal Care Segment
| For the Three Months Ended June 30, |
For the Six Months Ended June 30, |
|||||||||||||||||||||||||||||||||||||||||||||||
| 2025 |
2024 |
Change |
2025 |
2024 |
Change |
|||||||||||||||||||||||||||||||||||||||||||
| % of |
% of |
% of |
% of |
|||||||||||||||||||||||||||||||||||||||||||||
| Segment |
Segment |
Segment |
Segment |
|||||||||||||||||||||||||||||||||||||||||||||
| Net Service |
Net Service |
Net Service |
Net Service |
|||||||||||||||||||||||||||||||||||||||||||||
| Amount |
Revenues |
Amount |
Revenues |
Amount |
% | Amount |
Revenues |
Amount |
Revenues |
Amount |
% | |||||||||||||||||||||||||||||||||||||
| (Amounts in Thousands, Except Percentages) |
(Amounts in Thousands, Except Percentages) |
|||||||||||||||||||||||||||||||||||||||||||||||
| Operating Results |
||||||||||||||||||||||||||||||||||||||||||||||||
| Net service revenues |
$ | 269,183 | 100.0 | % | $ | 212,817 | 100.0 | % | $ | 56,366 | 26.5 | % | $ | 527,469 | 100.0 | % | $ | 420,820 | 100.0 | % | $ | 106,649 | 25.3 | % | ||||||||||||||||||||||||
| Cost of services revenues |
193,380 | 71.8 | 152,755 | 71.8 | 40,625 | 26.6 | 380,344 | 72.1 | 305,291 | 72.5 | 75,053 | 24.6 | ||||||||||||||||||||||||||||||||||||
| Gross profit |
75,803 | 28.2 | 60,062 | 28.2 | 15,741 | 26.2 | 147,125 | 27.9 | 115,529 | 27.5 | 31,596 | 27.3 | ||||||||||||||||||||||||||||||||||||
| General and administrative expenses |
24,163 | 9.0 | 16,973 | 8.0 | 7,190 | 42.4 | 47,894 | 9.1 | 32,418 | 7.7 | 15,476 | 47.7 | ||||||||||||||||||||||||||||||||||||
| Segment operating income |
$ | 51,640 | 19.2 | % | $ | 43,089 | 20.3 | % | $ | 8,551 | 19.8 | % | $ | 99,231 | 18.8 | % | $ | 83,111 | 19.8 | % | $ | 16,120 | 19.4 | % | ||||||||||||||||||||||||
| Business Metrics (Actual Numbers, Except Billable Hours in Thousands) |
||||||||||||||||||||||||||||||||||||||||||||||||
| Locations at period end |
199 | 153 | ||||||||||||||||||||||||||||||||||||||||||||||
| Average billable census * (1) |
50,404 | 37,993 | 12,411 | 32.7 | % | 50,442 | 37,854 | 12,588 | 33.3 | % | ||||||||||||||||||||||||||||||||||||||
| Billable hours * (2) |
10,558 | 7,732 | 2,826 | 36.5 | 20,760 | 15,322 | 5,438 | 35.5 | ||||||||||||||||||||||||||||||||||||||||
| Average billable hours per census per month * (2) |
69.8 | 67.7 | 2.1 | 3.1 | 68.6 | 67.4 | 1.2 | 1.8 | ||||||||||||||||||||||||||||||||||||||||
| Billable hours per business day * (2) |
162,436 | 118,956 | 43,480 | 36.6 | 160,927 | 117,862 | 43,065 | 36.5 | ||||||||||||||||||||||||||||||||||||||||
| Revenues per billable hour * (2) |
$ | 25.49 | $ | 27.47 | $ | (1.98 | ) | (7.2 | )% | $ | 25.41 | $ | 27.41 | $ | (2.00 | ) | (7.3 | )% | ||||||||||||||||||||||||||||||
| Same store growth revenue % * (3) |
7.4 | % | 8.8 | % | (1.4 | ) | (15.9 | ) | 7.4 | % | 9.3 | % | (1.9 | ) | (20.4 | ) | ||||||||||||||||||||||||||||||||
| (1) |
Average billable census is the number of unique clients receiving a billable service during the year and is the total census divided by months in operation during the period. |
| (2) |
Billable hours is the total number of hours served to clients during the period. Average billable hours per census per month is billable hours divided by average billable census. Billable hours per day is total billable hours divided by the number of business days in the period. Revenues per billable hour is revenue, attributed to billable bonus hours, divided by billable hours. |
| (3) |
Same store growth reflects the change in year-over-year revenue for the same store base. We define the same store base to include those stores open for at least 52 full weeks. This measure highlights the performance of existing stores, while excluding the impact of acquisitions, new store openings and closures and ARPA associated revenue from this calculation. |
* Management deems these metrics to be key performance indicators. Management uses these metrics to monitor our performance, both in our existing operations and acquisitions. Many of these metrics serve as the basis of reported revenues and assessment of these provide direct correlation to the results of operations from period to period and facilitate comparison with the results of our peers. Historical trends established in these metrics can be used to evaluate current operating results, identify trends affecting our business, determine the allocation of resources and assess the quality and potential variability of our cash flows and earnings. We believe they are useful to investors in evaluating and understanding our business but should not be used solely in assessing the Company’s performance. These key performance indicators should not be considered superior to, as a substitute for or as an alternative to, and should be considered in conjunction with, the GAAP financial measures presented herein to fully evaluate and understand the business as a whole. These measures may not be comparable to similarly titled performance indicators used by other companies.
The personal care segment derives a significant amount of its net service revenues from operations in Illinois, which represented 33.0% and 38.6% of our net service revenues for the three months ended June 30, 2025 and 2024, respectively, and accounted for 33.0% and 38.5% of our net service revenues for the six months ended June 30, 2025 and 2024, respectively. One payor, the Illinois Department on Aging, accounted for 18.6% and 21.1% of net service revenues for the three months ended June 30, 2025 and 2024, respectively, and accounted for 18.6% and 20.9% of net service revenues for the six months ended June 30, 2025 and 2024, respectively.
Net service revenues from state, local, and other governmental programs accounted for 51.4% and 53.1% of net service revenues for the three months ended June 30, 2025 and 2024, respectively. Managed care organizations accounted for 45.3% and 44.2% of net service revenues for the three months ended June 30, 2025 and 2024, respectively, with commercial insurance, private pay, and other payors accounting for the remainder of net service revenues. Net service revenues from state, local, and other governmental programs accounted for 51.4% and 52.5% of net service revenues for the six months ended June 30, 2025 and 2024, respectively. Managed care organizations accounted for 45.3% and 44.8% of net service revenues for the six months ended June 30, 2025 and 2024, respectively, with commercial insurance, private pay, and other payors accounting for the remainder of net service revenues.
Net service revenues increased by 26.5% for the three months ended June 30, 2025 compared to the three months ended June 30, 2024. Net service revenues included a 7.2% decrease in revenues per billable hour for the three months ended June 30, 2025, due to lower reimbursement rates attributable to the Gentiva Acquisition, as well as the New York Asset Sale, compared to the three months ended June 30, 2024.
Gross profit, expressed as a percentage of net service revenues, increased to 27.9% for the six months ended June 30, 2025 from 27.5% for the six months ended June 30, 2024. This increase was due to decreases in direct payroll and benefits expenses as a percentage of revenue for the six months ended June 30, 2025 primarily related to the New York Asset Sale.
The personal care segment’s general and administrative expenses primarily consist of administrative employee wages, taxes, and benefit costs, rent, information technology, and office expenses. General and administrative expenses, expressed as a percentage of net service revenues, was 9.1% and 7.7% for the six months ended June 30, 2025 and 2024, respectively.
Hospice Segment
| For the Three Months Ended June 30, |
For the Six Months Ended June 30, |
|||||||||||||||||||||||||||||||||||||||||||||||
| 2025 |
2024 |
Change |
2025 |
2024 |
Change |
|||||||||||||||||||||||||||||||||||||||||||
| % of |
% of |
% of |
% of |
|||||||||||||||||||||||||||||||||||||||||||||
| Segment |
Segment |
Segment |
Segment |
|||||||||||||||||||||||||||||||||||||||||||||
| Net Service |
Net Service |
Net Service |
Net Service |
|||||||||||||||||||||||||||||||||||||||||||||
| Amount |
Revenues |
Amount |
Revenues |
Amount |
% | Amount |
Revenues |
Amount |
Revenues |
Amount |
% | |||||||||||||||||||||||||||||||||||||
| (Amounts in Thousands, Except Percentages) |
(Amounts in Thousands, Except Percentages) |
|||||||||||||||||||||||||||||||||||||||||||||||
| Operating Results |
||||||||||||||||||||||||||||||||||||||||||||||||
| Net service revenues |
$ | 62,212 | 100.0 | % | $ | 56,030 | 100.0 | % | $ | 6,182 | 11.0 | % | $ | 123,649 | 100.0 | % | $ | 111,893 | 100.0 | % | $ | 11,756 | 10.5 | % | ||||||||||||||||||||||||
| Cost of services revenues |
32,414 | 52.1 | 29,730 | 53.1 | 2,684 | 9.0 | 64,684 | 52.3 | 58,697 | 52.5 | 5,987 | 10.2 | ||||||||||||||||||||||||||||||||||||
| Gross profit |
29,798 | 47.9 | 26,300 | 46.9 | 3,498 | 13.3 | 58,965 | 47.7 | 53,196 | 47.5 | 5,769 | 10.8 | ||||||||||||||||||||||||||||||||||||
| General and administrative expenses |
14,975 | 24.1 | 13,466 | 24.0 | 1,509 | 11.2 | 29,526 | 23.9 | 26,905 | 24.0 | 2,621 | 9.7 | ||||||||||||||||||||||||||||||||||||
| Segment operating income |
$ | 14,823 | 23.8 | % | $ | 12,834 | 22.9 | % | $ | 1,989 | 15.5 | % | $ | 29,439 | 23.8 | % | $ | 26,291 | 23.5 | % | $ | 3,148 | 12.0 | % | ||||||||||||||||||||||||
| Business Metrics (Actual Numbers) |
||||||||||||||||||||||||||||||||||||||||||||||||
| Locations at period end |
38 | 38 | ||||||||||||||||||||||||||||||||||||||||||||||
| Admissions * (1) |
3,260 | 3,194 | 66 | 2.1 | % | 6,734 | 6,666 | 68 | 1.0 | % | ||||||||||||||||||||||||||||||||||||||
| Average daily census * (2) |
3,720 | 3,477 | 243 | 7.0 | 3,618 | 3,418 | 200 | 5.9 | ||||||||||||||||||||||||||||||||||||||||
| Average discharge length of stay * (3) |
90.6 | 92.6 | (2.0 | ) | (2.2 | ) | 94.1 | 91.1 | 3.0 | 3.3 | ||||||||||||||||||||||||||||||||||||||
| Patient days * (4) |
338,505 | 316,451 | 22,054 | 7.0 | 654,824 | 622,081 | 32,743 | 5.3 | ||||||||||||||||||||||||||||||||||||||||
| Revenue per patient day * (5) |
$ | 184.92 | $ | 179.47 | $ | 5.45 | 3.0 | $ | 189.42 | $ | 181.10 | $ | 8.32 | 4.6 | ||||||||||||||||||||||||||||||||||
| Organic growth |
||||||||||||||||||||||||||||||||||||||||||||||||
| - Revenue * (6) |
10.0 | % | 6.3 | % | 3.7 | 58.7 | 9.9 | % | 6.1 | % | 3.8 | 62.3 | ||||||||||||||||||||||||||||||||||||
| - Average daily census * (6) |
7.0 | % | 1.7 | % | 5.3 | 311.8 | % | 5.8 | % | 0.4 | % | 5.4 | 1350.0 | % | ||||||||||||||||||||||||||||||||||
| (1) |
Represents referral process and new patients on service during the period. |
| (2) |
Average daily census is total patient days divided by the number of days in the period. |
| (3) |
Average length of stay is the average number of days a patient is on service, calculated upon discharge, and is total patient days divided by total discharges in the period. |
| (4) |
Patient days is days of service for all patients in the period. |
| (5) |
Revenue per patient day is hospice revenue divided by the number of patient days in the period. |
| (6) |
Revenue organic growth and average daily census organic growth reflect the change in year-over-year revenue and average daily census for the same store base. We define the same store base to include those stores open for at least 52 full weeks. These measures highlight the performance of existing stores, while excluding the impact of acquisitions, new store openings and closures. |
* Management deems these metrics to be key performance indicators. Management uses these metrics to monitor our performance, both in our existing operations and acquisitions. Many of these metrics serve as the basis of reported revenues and assessment of these provide direct correlation to the results of operations from period to period and facilitate comparison with the results of our peers. Historical trends established in these metrics can be used to evaluate current operating results, identify trends affecting our business, determine the allocation of resources and assess the quality and potential variability of our cash flows and earnings. We believe they are useful to investors in evaluating and understanding our business but should not be used solely in assessing the Company’s performance. These key performance indicators should not be considered superior to, as a substitute for or as an alternative to, and should be considered in conjunction with, the GAAP financial measures presented herein to fully evaluate and understand the business as a whole. These measures may not be comparable to similarly titled performance indicators used by other companies.
The hospice segment generates revenue by providing care to patients with a life expectancy of six months or less, as well as related services for their families. Hospice offers four levels of care, as defined by Medicare, to meet the varying needs of patients and their families. The four levels of hospice include routine home care, continuous home care, general inpatient care and respite care. Our hospice segment principally provides routine home care.
Net service revenues from Medicare accounted for 93.0% and 91.2% for the three months ended June 30, 2025 and 2024, respectively, and 92.7% and 91.0% for the six months ended June 30, 2025 and 2024, respectively. Net service revenues from managed care organizations accounted for 3.2% and 3.4% for the three months ended June 30, 2025 and 2024, respectively, and for 3.3% for both the six months ended June 30, 2025 and 2024.
Net service revenues increased by $6.2 million and $11.8 million for the three and six months ended June 30, 2025 compared to the three and six months ended June 30, 2024, primarily attributed to organic growth in average daily census.
Gross profit, expressed as a percentage of net service revenues, was 47.9% and 46.9% for the three months ended June 30, 2025 and 2024, respectively, and 47.7% and 47.5% for the six months ended June 30, 2025 and 2024, respectively. For the three and six months ended June 30, 2025, the increase was mainly attributed to organic growth.
The hospice segment’s general and administrative expenses primarily consist of administrative employee wage, tax, and benefit costs, rent, information technology, and office expenses. General and administrative expenses, expressed as a percentage of net service revenues, was 24.1% and 24.0% for the three months ended June 30, 2025 and 2024, respectively, and 23.9% and 24.0% for the six months ended June 30, 2025 and 2024, respectively.
Home Health Segment
| For the Three Months Ended June 30, |
For the Six Months Ended June 30, |
|||||||||||||||||||||||||||||||||||||||||||||||
| 2025 |
2024 |
Change |
2025 |
2024 |
Change |
|||||||||||||||||||||||||||||||||||||||||||
| % of |
% of |
% of |
% of |
|||||||||||||||||||||||||||||||||||||||||||||
| Segment |
Segment |
Segment |
Segment |
|||||||||||||||||||||||||||||||||||||||||||||
| Net Service |
Net Service |
Net Service |
Net Service |
|||||||||||||||||||||||||||||||||||||||||||||
| Amount |
Revenues |
Amount |
Revenues |
Amount |
% | Amount |
Revenues |
Amount |
Revenues |
Amount |
% | |||||||||||||||||||||||||||||||||||||
| (Amounts in Thousands, Except Percentages) |
(Amounts in Thousands, Except Percentages) |
|||||||||||||||||||||||||||||||||||||||||||||||
| Operating Results |
||||||||||||||||||||||||||||||||||||||||||||||||
| Net service revenues |
$ | 18,048 | 100.0 | % | $ | 18,075 | 100.0 | % | $ | (27 | ) | (0.1 | )% | $ | 36,033 | 100.0 | % | $ | 34,955 | 100.0 | % | $ | 1,078 | 3.1 | % | |||||||||||||||||||||||
| Cost of services revenues |
9,771 | 54.1 | 11,279 | 62.4 | (1,508 | ) | (13.4 | ) | 20,569 | 57.1 | 22,345 | 63.9 | (1,776 | ) | (7.9 | ) | ||||||||||||||||||||||||||||||||
| Gross profit |
8,277 | 45.9 | 6,796 | 37.6 | 1,481 | 21.8 | 15,464 | 42.9 | 12,610 | 36.1 | 2,854 | 22.6 | ||||||||||||||||||||||||||||||||||||
| General and administrative expenses |
3,895 | 21.6 | 4,572 | 25.3 | (677 | ) | (14.8 | ) | 8,068 | 22.4 | 9,109 | 26.1 | (1,041 | ) | (11.4 | ) | ||||||||||||||||||||||||||||||||
| Segment operating income |
$ | 4,382 | 24.3 | % | $ | 2,224 | 12.3 | % | $ | 2,158 | 97.0 | % | $ | 7,396 | 20.5 | % | $ | 3,501 | 10.0 | % | $ | 3,895 | 111.3 | % | ||||||||||||||||||||||||
| Business Metrics (Actual Numbers) |
||||||||||||||||||||||||||||||||||||||||||||||||
| Locations at period end |
23 | 23 | ||||||||||||||||||||||||||||||||||||||||||||||
| New admissions * (1) |
4,568 | 4,993 | (425 | ) | (8.5 | )% | 9,276 | 9,820 | (544 | ) | (5.5 | )% | ||||||||||||||||||||||||||||||||||||
| Recertifications * (2) |
2,833 | 3,277 | (444 | ) | (13.5 | ) | 5,815 | 6,445 | (630 | ) | (9.8 | ) | ||||||||||||||||||||||||||||||||||||
| Total volume * (3) |
7,401 | 8,210 | (809.0 | ) | (9.9 | ) | 15,091 | 16,265 | (1,174.0 | ) | (7.2 | ) | ||||||||||||||||||||||||||||||||||||
| Visits * (4) |
94,692 | 111,053 | (16,361 | ) | (14.7 | ) | 189,285 | 217,984 | (28,699 | ) | (13.2 | ) | ||||||||||||||||||||||||||||||||||||
| Organic growth |
||||||||||||||||||||||||||||||||||||||||||||||||
| - Revenue * (5) |
(6.0 | )% | 1.6 | % | (7.6 | ) | (475.0 | ) | (2.5 | )% | (7.1 | )% | 4.6 | (64.8 | ) | |||||||||||||||||||||||||||||||||
| - Admissions * (5) |
(7.6 | )% | 9.4 | % | (17.0 | ) | (180.9 | )% | (5.6 | )% | 2.3 | % | (7.9 | ) | (343.5 | )% | ||||||||||||||||||||||||||||||||
| (1) |
Represents new patients during the period. |
| (2) |
A home health certification period is an episode of care that begins with a start of care visit and continues for 60 days. If at the end of the initial episode of care, the patient continues to require home health services, a recertification is required. This represents the number of recertifications during the period. |
| (3) |
Total volume is total admissions and total recertifications in the period. |
| (4) |
Represents number of services to patients in the period. |
| (5) |
Revenue organic growth and admissions organic growth reflect the change in year-over-year revenue and admissions for the same store base. We define the same store base to include those stores open for at least 52 full weeks. These measures highlight the performance of existing stores, while excluding the impact of acquisitions, new store openings, and closures. |
* Management deems these metrics to be key performance indicators. Management uses these metrics to monitor our performance, both in our existing operations and acquisitions. Many of these metrics serve as the basis of reported revenues and assessment of these provide direct correlation to the results of operations from period to period and facilitate comparison with the results of our peers. Historical trends established in these metrics can be used to evaluate current operating results, identify trends affecting our business, determine the allocation of resources and assess the quality and potential variability of our cash flows and earnings. We believe they are useful to investors in evaluating and understanding our business but should not be used solely in assessing the Company’s performance. These key performance indicators should not be considered superior to, as a substitute for or as an alternative to, and should be considered in conjunction with, the GAAP financial measures presented herein to fully evaluate and understand the business as a whole. These measures may not be comparable to similarly titled performance indicators used by other companies.
The home health segment generates net service revenues by providing home health services on a short-term, intermittent or episodic basis to individuals, generally to treat an illness or injury. Net service revenues from Medicare accounted for 69.4% and 69.3%, managed care organizations accounted for 23.6% and 25.9%, and state, local, and other governmental programs accounted for 4.4% and 0.2% for the three months ended June 30, 2025 and 2024, respectively. Net service revenues from Medicare accounted for 69.7% and 69.2%, managed care organizations accounted for 22.4% and 26.0%, and state, local, and other governmental programs accounted for 5.2% and 0.2% for the six months ended June 30, 2025 and 2024, respectively. Home health services provided to Medicare beneficiaries are paid under the Medicare Home Health Prospective Payment System, which uses national, standardized 30-day period payment rates for periods of care. CMS uses the PDGM as the case-mix classification model to place periods of care into payment categories, classifying patients based on clinical characteristics. An outlier adjustment may be paid for periods of care in which costs exceed a specific threshold amount.
Net service revenues remained constant for the three months ended June 30, 2025, compared to the three months ended June 30, 2024, and increased by $1.1 million for the six months ended June 30, 2025, compared to the six months ended June 30, 2024, primarily due to the Gentiva Acquisition.
Gross profit, expressed as a percentage of net service revenues, was 45.9% and 37.6% for the three months ended June 30, 2025 and 2024, respectively, and 42.9% and 36.1% for the six months ended June 30, 2025 and 2024, respectively. For the three and six months ended June 30, 2025, the increase was mainly attributed to a decrease in direct care wages, taxes and benefit costs as a percentage of net service revenues, compared to the three and six months ended June 30, 2024.
The home health segment’s general and administrative expenses primarily consist of administrative employee wage, tax and benefit costs, rent, information technology, and office expenses. General and administrative expenses, expressed as a percentage of net service revenues, was 21.6% and 25.3% for the three months ended June 30, 2025 and 2024, respectively, and 22.4% and 26.1% for the six months ended June 30, 2025 and 2024, respectively. General and administrative expenses for the three and six months ended June 30, 2025 decreased compared to the corresponding period in 2024, primarily due to more efficient operations for administrative employees for the three and six months ended June 30, 2025.
Liquidity and Capital Resources
Overview
Our primary sources of liquidity are cash on hand and cash from operations and borrowings under our credit facility. At June 30, 2025 and December 31, 2024, we had cash balances of $91.2 million and $98.9 million, respectively. At June 30, 2025, we had a $650.0 million revolving credit facility and a $150.0 million incremental loan facility, which may be for term loans or an increase to the revolving loan commitments. The maturity of this credit facility was extended to July 30, 2028.
During the six months ended June 30, 2025, we used $3.4 million in cash to fund the Jacksonville Acquisition and the Great Lakes Acquisition and repaid $50.0 million under our revolving credit facility. As of June 30, 2025, we had a total of $173.0 million in revolving loans, with an interest rate of 6.07% outstanding on our credit facility and after giving effect to the amount drawn on our credit facility, approximately $8.0 million of outstanding letters of credit and borrowing limits based on an advance multiple of adjusted EBITDA (as defined in the Credit Agreement), we had $635.6 million of capacity and $454.6 million available for borrowing under our credit facility. At December 31, 2024, we had a total of $223.0 million revolving credit loans, with an interest rate of 6.34%, outstanding on our credit facility.
Our credit facility requires us to maintain a total net leverage ratio not exceeding 3.75:1.00. At June 30, 2025, we were in compliance with our financial covenants under the Credit Agreement. Although we believe our liquidity position remains strong, we can provide no assurance that we will remain in compliance with the covenants in our Credit Agreement, and in the future, it may prove necessary to seek an amendment with the bank lending group under our credit facility. Additionally, there can be no assurance that we will be able to raise additional funds on terms acceptable to us, if at all.
See Note 8 to the Notes to Unaudited Condensed Consolidated Financial Statements, Long-Term Debt, for additional details of our long-term debt.
Current Macroeconomic Conditions and American Rescue Plan Act of 2021 Relief Funding
Economic conditions in the United States continue to be challenging in various respects. For example, the United States economy continues to experience inflationary pressures, elevated interest rates, challenging labor market conditions and uncertainty regarding the impact of increased tariffs and trade disruptions. Any economic downturn would pose a risk to states’ revenues, which in turn could affect our reimbursements and collections received for services rendered. Depending on the severity and length of any potential economic downturn as well as the extent of any federal support, states could face significant fiscal challenges and revise their revenue forecasts and adjust their budgets, and sales tax collections and income tax withholdings could be depressed.
ARPA Spending Plans
To mitigate the fiscal effects of the COVID-19 public health emergency, the ARPA provided for a 10 percentage point increase in federal matching funds for Medicaid HCBS from April 1, 2021, through March 31, 2022, provided the state satisfied certain conditions. States were generally permitted to use the state funds equivalent to the additional federal funds through March 31, 2025, but CMS granted extensions to several states, permitting some state spending plans to continue until as late as mid-2026. States must use the monies attributable to this matching fund increase to supplement, not supplant, their level of state spending for the implementation of activities enhanced under the Medicaid HCBS in effect as of April 1, 2021.
HCBS spending plans for the additional matching funds vary by state, but common initiatives in which the Company is participating include those aimed at strengthening the provider workforce (e.g., efforts to recruit, retain, and train direct service providers). The Company is required to properly and fully document the use of such funds in reports to the state in which the funds originated. Funds may be subject to recoupment if not expended or if they are expended on non-approved uses.
During the three and six months ended June 30, 2025, the Company did not receive additional state funding provided by the ARPA. Of the total state funding received by the Company pursuant to the ARPA through June 30, 2025, the Company utilized $0.8 million and $3.3 million during the three and six months ended June 30, 2025, respectively, primarily for caregivers and adding support to recruiting and retention efforts, included as a reduction of cost of service revenues in the Company’s Unaudited Condensed Consolidated Statements of Income. As of June 30, 2025, the deferred portion of ARPA funding of $7.9 million is included within Government stimulus advances on the Company’s Unaudited Condensed Consolidated Balance Sheets.
The following table summarizes changes in our cash flows:
| For the Six Months Ended June 30, |
||||||||
| 2025 |
2024 |
|||||||
| (Amounts in Thousands) |
||||||||
| Net cash provided by operating activities |
$ | 41,478 | $ | 57,491 | ||||
| Net cash used in investing activities |
317 | 1,798 | ||||||
| Net cash (used in) provided by financing activities |
(49,530 | ) | 49,225 | |||||
Six Months Ended June 30, 2025 Compared to Six Months Ended June 30, 2024
Cash flows from operating activities represent the inflow of cash from our payors and the outflow of cash for payroll and payroll taxes, operating expenses, interest, and taxes. Net cash provided by operating activities was $41.5 million for the six months ended June 30, 2025, compared to net cash provided by operating activities of $57.5 million for the same period in 2024. The decrease in cash provided by operations was primarily due to the timing of receipts on accounts receivable and the timing of government stimulus funds. The changes in accounts receivable were primarily related to the growth in revenue and a decrease in days sales outstanding (“DSO”) during the six months ended June 30, 2025 as compared to the six months ended June 30, 2024. The related receivables due from the Illinois Department on Aging represented 18.6% and 21.7% of the Company’s net accounts receivable at June 30, 2025 and June 30, 2024, respectively.
Net cash used in investing activities for the six months ended June 30, 2025, primarily consisted of $3.4 million of net cash used for the Jacksonville Acquisition and the Great Lakes Acquisition, $3.1 million of cash used for property and equipment purchases, primarily related to our ongoing investments in technology infrastructure fixed assets, offset by $3.8 million in proceeds received relating to the New York Asset Sale and $2.9 million in proceeds received relating to the Gentiva Acquisition. Net cash used in investing activities for the six months ended June 30, 2024 primarily consisted of $0.4 million of net cash used for the Upstate acquisition and $2.4 million of cash used for property and equipment purchases, offset by $4.6 million in proceeds received relating to the New York Asset Sale.
Net cash used in financing activities for the six months ended June 30, 2025, primarily consisted of a $50.0 million payment on our revolving credit facility, offset by cash received from the exercise of stock options of $0.5 million. Net cash used in financing activities for the six months ended June 30, 2024 primarily consisted of $126.4 million payment on our revolving credit facility, offset by $175.6 million in net proceeds received from the Public Offering.
Outstanding Accounts Receivable
Gross accounts receivable as of June 30, 2025 and December 31, 2024 were approximately $143.1 million and $126.4 million, respectively. Outstanding accounts receivable, net of allowance for credit losses, increased by $17.2 million as of June 30, 2025 as compared to December 31, 2024. Accounts receivable for the Illinois Department on Aging increased approximately $6.3 million during the six months ended June 30, 2025. Our collection procedures include review of account aging and direct contact with our payors. We have historically not used collection agencies. An uncollectible amount is written off to the allowance account after reasonable collection efforts have been exhausted.
We calculate our DSO by taking the trade accounts receivable outstanding, net of allowance for credit losses for doubtful accounts, divided by the net service revenues for the last quarter, multiplied by the number of days in that quarter. Our DSOs were 38 days and 39 days at June 30, 2025 and December 31, 2024, respectively. The DSOs for our largest payor, the Illinois Department on Aging, were 39 days and 40 days at June 30, 2025 and December 31, 2024, respectively.
Off-Balance Sheet Arrangements
As of June 30, 2025, we did not have any off-balance sheet guarantees or arrangements with unconsolidated entities.
Critical Accounting Policies and Estimates
There have been no material changes to our critical accounting policies and estimates previously disclosed under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Policies and Estimates” set forth in Part II, Item 7 of our Annual Report on Form 10-K for the period ended December 31, 2024, filed on February 25, 2025.
Recently Issued Accounting Pronouncements
Refer to Note 2 to the Notes to Unaudited Condensed Consolidated Financial Statements for further discussion.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We are exposed to market risk associated with changes in interest rates on our variable rate long-term debt. As of June 30, 2025, we had outstanding borrowings of approximately $173.0 million on our credit facility, all of such borrowings were subject to variable interest rates. If the variable rates on this debt were 100 basis points higher than the rate applicable to the borrowing during the six month period ended June 30, 2025, our net income would have decreased by $0.8 million, or $0.04 per diluted share. We do not currently have any derivative or hedging arrangements, or other known exposures, to changes in interest rates.
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of June 30, 2025. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) means controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act, is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
Based on the evaluation of our disclosure controls and procedures, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of June 30, 2025.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the fiscal quarter ended June 30, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II – OTHER INFORMATION
Item 1. Legal Proceedings
Legal Proceedings
From time to time, we are subject to legal and/or administrative proceedings incidental to our business. It is the opinion of management that the outcome of pending legal and/or administrative proceedings will not have a material effect on our financial position and results of operations.
Item 1A. Risk Factors
Investing in our common stock involves a high degree of risk. You should carefully consider the risk factors discussed under the caption “Risk Factors” set forth in Part I, Item 1A, of our Annual Report on Form 10-K for the year ended December 31, 2024, filed on February 25, 2025. There have been no material changes to the risk factors previously disclosed under the caption “Risk Factors” in our Annual Report on Form 10-K. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition, or operating results.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
None.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
None.
Item 5. Other Information
Not applicable. Without limiting the generality of the foregoing, during the quarter ended June 30, 2025, no director or Section 16 officer adopted or terminated any Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements, as such terms are defined in Item 408(a) of Regulation S-K.
Item 6. Exhibits
EXHIBIT INDEX
| Incorporated by Reference |
||||||||||
| Exhibit Number |
Description of Document |
Form |
File No. |
Date Filing |
Exhibit Number |
|||||
| 3.1 |
Amended and Restated Certificate of Incorporation of the Company dated as of October 27, 2009. |
10-Q |
001-34504 |
11/20/2009 |
3.1 |
|||||
| 3.2 |
Amended and Restated Bylaws of the Company, as amended by the First Amendment to the Amended and Restated Bylaws. |
10-Q |
001-34504 |
05/09/2013 |
3.2 |
|||||
| 4.1 |
Form of Common Stock Certificate. |
S-1 |
333-160634 |
10/02/2009 |
4.1 |
|||||
| 31.1 |
Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934 as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
|||||||||
| 31.2 |
Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934 as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
|||||||||
| 32.1 |
Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
|||||||||
| 32.2 |
Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
|||||||||
| 101.INS |
|
Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document). |
||||||||
| 101.SCH |
|
Inline XBRL Taxonomy Extension Schema Document. |
||||||||
| 101.CAL |
|
Inline XBRL Taxonomy Calculation Linkbase Document. |
||||||||
| 101.LAB |
|
Inline XBRL Taxonomy Label Linkbase Document. |
||||||||
| 101.PRE |
|
Inline XBRL Presentation Linkbase Document. |
||||||||
| 101.DEF |
|
Inline XBRL Taxonomy Extension Definition Linkbase Document. |
||||||||
| 104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101). |
||||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| ADDUS HOMECARE CORPORATION |
||
| Date: August 5, 2025 |
By: |
/s/ R. DIRK ALLISON |
|
|
R. Dirk Allison Chairman and Chief Executive Officer (As Principal Executive Officer) |
|
| Date: August 5, 2025 |
By: |
/s/ BRIAN POFF |
| Brian Poff Chief Financial Officer (As Principal Financial Officer) |
||
FAQ
How many Arteris (AIP) shares are planned for sale in this Form 144?
What is the estimated value of the planned insider sale?
How much has the insider already sold in the past 3 months?
Does the sale rely on a Rule 10b5-1 trading plan?
What percentage of Arteris’s outstanding shares does the new sale represent?
Were the shares purchased or option-derived?
